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Table 1: Common and recently developed astrocyte monoculture protocols. 






Aldh1L1 aldehyde dehydrogenase 1 family member L1 
βIIItub  beta III tubulin 
bp  base pairs  
BSA  bovine serum albumin  
°C  degrees Celsius (centigrades)  
DAPI  4'-6-Diamidino-2-phenylindole  
ddH2O double distilled (or miliQ) water  
EDTA  ethylened acid  
E  embryonic day 
e.g.  exempli gratia  
EEA1  early endosome antigen 1 
g  standard gravity  
Gfap  glial fibrillary acidic protein 
GFP  green fluorescent protein 
HRP  horse radish peroxidase 
IP  immunopanning, refers to the IP culture method (Foo et al., 2011)(McCarthy 
and de Vellis, 1980)(McCarthy and de Vellis, 1980)(McCarthy and de Vellis, 
1980)(McCarthy and de Vellis, 1980)(McCarthy and de Vellis, 1980) 
iPSC  induced pluripotent stem cell 
Itgb5  integrin beta 5 
kDa  kilodalton  
M  Molar  
Map2  microtubule-associated protein 2 
Mbp  myelin basic protein 
MD  refers to the MD culture method (McCarthy and de Vellis, 1980) 
μM  micromolar  
mM  millimolar 
min  minutes  
ml   milliliter  
μg  microgram  
μl  microliter  
NB+H  refers to the NB+H culture method developed here 
ng  nanogram  
n.s.  non-significant  
μm  micrometer  
nm  nanometer  
p  p value  
P  postnatal day  
PAGE  polyacrylamide gel electrophoresis  
PBS  phosphate buffered saline  
PCR  polymerase chain reaction  
s  seconds  
SDS  sodium dodecyl sulfate  
SEM  standard error of the mean 
Snap  synaptosomal-associated protein 
Stx  syntaxin 
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Syp  synaptophysin 
Syt  synaptotagmin  
TSP1  thrombospondin1 
Wt  wild-type  
w/v  weight per volume  
U  unit (for enzyme activities)  
UV  ultraviolet  
V  Volt  
Vamp  vesicle-associated membrane protein 
vGluT  vesicular glutamate transporter 
 




Astrocytes are key to neuronal trophic support, development, and synaptic signalling and 
plasticity. Astrocytes can detect synaptic events at tripartite synapses –a major site of 
bidirectional communication between neurones and astrocytes– and alter synaptic function by 
gliotransmitter release. This is reflected in basic research studies as well as 
neurodevelopmental disease models, where astrocyte-derived factors shape synapse structure 
and function. Despite the many roles of astrocytes in brain (patho-) physiology, the 
mechanisms that underlie release of gliotransmitters to affect astro-neuronal communication 
are poorly understood. 
 To investigate astrocytic signalling at synaptic interfaces and which molecules 
mediate astrocytic vesicle fusion, I developed a simple and economical protocol for growing 
more “in vivo-like” astrocyte monocultures. In comparison to other astrocyte monocultures, 
spontaneous Ca2+ signalling in astrocytes of my protocol was more similar to that of 
astrocytes co-cultured with neurones. Moreover, I observed distinct subcellular domains in 
which different Ca2+ event types occurred that were similar to those of astrocytes in slices and 
in vivo. 
Using this culture protocol, I confirmed that astrocytes express several vesicle-
associated proteins, two of which localised to two distinct vesicle populations that underwent 
recycling: Vamp2 and Syt7. Vamp2 was previously found in astrocytes, and cleaving Vamp2 
by clostridial toxins blocks Ca2+-dependent glutamate release from astrocytes. Syt7, which is 
implicated in lysosomal secretion in different cell types (but also regulates synaptic vesicle 
replenishment), is a Ca2+ sensor with high Ca2+ affinity that has not yet been reported in 
astrocytes. The Ca2+ signalling patterns I observed in cultured astrocytes provide a context for 
Syt7-mediated vesicle fusion, which I further investigated using Syt7-/- mouse cultures: When 
co-cultured with Syt7-/- astrocytes, wild-type neurones had fewer synapses. Further, I showed 
that Syt7 and the synaptogenic factor Hevin are developmentally regulated and partially co-
localise in cultured astrocytes. These data suggest that Syt7 may regulate vesicular Hevin 
release from astrocytes, which in turn shapes how neuronal circuits develop. Astrocytic 
exocytosis contributes to neurodevelopmental diseases, where aberrant astrocytic Hevin 
release has been implicated in epileptogenesis. Together, these data support that astrocytic 
Syt7 (and perhaps other Syts) may mediate the release of astrocytic factors that are important 
for brain development. 




2.1 Astrocytes in the healthy brain 
Already over a century ago, Santiago Ramón y Cajal suggested a greater role for glia than just 
acting as ‘glue’ that keeps neurones together (García-Marín et al., 2007). Indeed, the main 
classes of glia play diverse and indispensable roles in nervous system physiology, from the 
myelinating oligodendrocytes in the brain or Schwann cells in the periphery to microglia 
(dubbed the brain’s immune system), and astrocytes, which maintain the blood-brain barrier 
and provide metabolic and homeostatic support for neurones. Glia likely contribute to the 
high cognitive abilities in humans, as from the bottom of the evolutionary tree to the top, the 
ratio of glia to neurones increases (Nedergaard et al., 2003; Sherwood et al., 2006). 
Astrocytes especially may contribute to intelligence, as a recent study suggests, in which mice 
with human astrocytes performed better in learning and memory tests than littermates (Han et 
al., 2013). 
 





 In the past few decades, glia have gained more attention, and their importance for 
neuronal network function is no longer thought to be restricted to structural, immune, and 
trophic support: Microglia and astrocytes in particular were shown to directly affect synaptic 
signalling and plasticity (Araque et al., 1999; Perea et al., 2009; Santello et al., 2012; Schafer 
et al., 2013), and oligodendrocytes and Schwann cells also provide nutrients to the axons they 
 
Fig. 1: Classical view of brain cell positions 
Schematic image of neurones with zoomed-in view of a synapse, glia, microglia, oligodendrocytes 
enwrapping axons with myelin sheaths, and an astrocyte contacting blood vessels via a perivascular 
endfoot. Together with pericytes (which also surround blood vessels), astrocytes form the blood -brain 
barrier, with tight junctions that restrict molecule and even small ion fluxes. Thus, compounds cannot 
easily cross the blood-brain barrier, which is a significant caveat for developing drugs that target 
neurones or glia in the brain. Modified image from Sankowski et al. (2015). 
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ensheath and communicate with neurones (Fields et al., 2014). Among these three major 
types of glia, the most subtypes and versatile functions were described for astrocytes. 
The different domains taken up by morphologically distinct astrocytes already hint at 
their high degree of specialisation. By brain area, astrocytes are categorised into cortical white 
matter fibrous astrocytes and grey matter protoplasmic astrocytes, cerebellar Bergmann glia, 
retinal Müller cells, and radial glia which first appear in the developing brain (and give rise to 
other astrocytes) but also exist in specialised adult brain areas where neurogenesis occurs (i.e. 
the subventricular zone along the walls of the lateral ventricles and the sub granular zone 
within the dentate gyrus of the hippocampus). 
On a subcellular scale, astrocytes feature structurally different and specialised 
domains, e.g. astrocytic endfeet, which contact blood vessels (Fig. 1). The term “astrocytic 
process” has been used ambiguously, but a specific nomenclature for astrocyte morphology 
was recently suggested (Tong et al., 2013): The large, primary processes of astrocytes 
(branches) split into smaller branchlets, which in turn separate into even thinner, specialised 
processes including endfeet (which contact the vasculature) and  leaflets (which contact 
synapses).  
 Although all of the astroglial subtypes mentioned above are considered astrocytes, a 
common marker protein that labels all astrocytes has yet to be identified. However, glial 
fibrillary acidic protein (Gfap) and aldehyde dehydrogenase 1 family member L1 (Aldh1L1) 
have been used to label the majority of astrocytes (Cahoy et al., 2008; Yang et al., 2011), 
although Aldh1L1 was also found in postnatal neural stem cells (Foo and Dougherty, 2013). 
Other markers expressed by astrocytes also label neurones, like Nestin (Messam et al., 2000), 
which is expressed by immature astrocytes and neural precursor cells, or S100β, which 
predominantly marks mature astrocytes but also other brain cells like oligodendrocytes 
(Donato et al., 2013; Steiner et al., 2008). The lack of a common astrocyte marker again 
illustrates how specialised different subtypes of astrocytes are. Indeed, astrocytes are multi-
taskers and fundamental to the blood-brain barrier, trophic support of neurones, ion 
homeostasis, development, and synaptic signalling and plasticity (Volterra and Meldolesi, 
2005). 
As shown in Fig. 1, the blood-brain barrier is formed by specialised astrocytic 
processes called endfeet, which wrap around blood vessels (Parri and Crunelli, 2003). Such 
contacts allow astrocytes to retrieve nutrients from the bloodstream and pass these on to 
neurones, e.g. astrocytes take up glucose via glucose transporters in their endfeet (Fernandez-
Fernandez et al., 2012; Prebil et al., 2011). At the same time, astrocytic endfeet are also 
Introduction – 2.1 Astrocytes in the healthy brain 
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involved in spatial [K+] buffering, thus contributing to ion homeostasis. Local extracellular 
[K+] increases (as caused by action potentials) can trigger undesired action potentials in 
neighbouring neuronal processes, and in situations with increased neural activity, favour 
epileptic discharge – but when astrocytes take up excess K+ from the extracellular space, high 
[K+] is quickly dispersed through gap junctions to other astrocytes, and finally released into 
the bloodstream (Walz, 2000). Astrocytes also take up excess glutamate. Like faulty K+ 
buffering, excess extracellular glutamate can also contribute to epilepsy by causing 
hyperexcitation and seizures, and is cytotoxic at high concentrations (Seifert and Steinhäuser, 
2013). Interestingly, clinical hallmarks of epileptic patients also include dysfunctional 
astrocytic glutamate transporters and glutamine synthetase (GS), which converts glutamate 
into glutamine, a key source for neuronal glutamate and thus neurotransmitter release.  
However, glutamate is not only taken up by astrocytes, but alongside other molecules, 
can also be released from astrocytes to alter synaptic signalling and plasticity (Barker and 
Ullian, 2010; Perea et al., 2009). The role of glial factors in synaptic function and 
communication between astrocytes and neurones will be discussed in more detail in chapter 
2.3.2. 
Astrocytes not only provide support of neural network activity, but in development 
they also guide neurones (Del Puerto et al., 2013) and directly affect myelination (Ishibashi et 
al., 2006) and synaptogenesis (Allen, 2013; Pfrieger, 2002). Key to steering such 
developmental processes, the release of astroglial factors has become a major focus within the 
field, not least because of the implications for neurodevelopmental diseases (Sloan and 
Barres, 2014a). For example, astrocyte-secreted factors contribute to the abnormal 
morphology of dendritic spines in fragile X syndrome and Down’s syndro me, and also 
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2.2 Astrocytes in neurodevelopmental diseases 
In terms of diseases associated with astrocytes, epilepsy first comes to mind. This disorder is 
characterised by epileptic seizures due to hyperexcitability and abnormal brain development 
(Caleo, 2009). As described in the previous chapter, astrocytes are key to spatial K+ and 
glutamate buffering, to prevent neurones from firing uncontrollably. Of note, dysfunctional 
astrocytes increase neuronal excitability and thereby exacerbate epileptic seizures (Gómez-
Gonzalo et al., 2010). Apart from adult astrocyte dysfunction in epilepsy, early postnatal 
development has recently received more attention as a contributing factor to epilepsy, since 
defective synapse elimination and/or refinement can also add to neuronal hyperexcitability 
(Bozzi et al., 2012). Epilepsy is also considered a neurodevelopmental disorder, since 
neuronal connections are established and refined soon after birth. Interestingly, astrocytes 
greatly influence synaptogenesis (e.g. by secreting synaptogenic factors), including synaptic 
elimination and remodelling (Clarke and Barres, 2013). 
Apart from neuronal circuit development, the importance of astrocytes for normal 
brain function becomes painfully clear in Alexander disease, which is a rare disorder caused 
by Gfap mutations in most cases. The majority of patients experience developmental delays, 
regression and seizures, and rarely survive until adulthood (Brenner et al., 2009). Although 
astrocytic dysfunction sits at its core, Alexander disease was initially described as a white 
matter disease (leukodystrophy) because of hypertrophic astrocytes scattered all throughout 
the white matter. Other astrogliopathies may therefore underlie disorders categorised as 
neuronal or myelin-related. 
 In fact, Rett syndrome is one such astrogliopathy that was first attributed to neuronal 
dysfunction. Rett syndrome is characterised by a lack of the transcriptional repressor methyl-
CpG-binding protein 2 (MeCP2), without which patients first lose acquired developmental 
progress and then develop autistic traits, cognitive impairment, and respiratory abnormalities 
that often lead to premature death (Chahrour and Zoghbi, 2007). Recently, astrocytes were 
found to express MeCP2 (Ballas et al., 2009). Further, wild-type (Wt) neurones developed 
abnormal dendrite morphology when exposed to either astrocytes or conditioned medium 
from mutant mouse cell cultures that lack MeCP2. These dendritic abnormalities were 
partially restored (along with normal movement and breathing) after conditional re-installing 
of MeCP2 function only in astrocytes of mutant mice. In a screen for differential gene 
expression in Wt and mutant mice lacking MeCP2, the genes for two secreted proteins 
(chromogranin B and lipocalin-2) were significantly downregulated (Delépine et al., 2015) in 
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MeCP2 knockout mice. The authors of this study suggested that astrocytes secrete less 
chromogranin B and lipocalin-2 in MeCP2 knockout mice, which in turn may lead to 
neuronal abnormalities in MeCP2-lacking mutant mice. These findings suggest that astrocytes 
play a more central role in Rett syndrome than neurones (Lioy et al., 2011). 
Another astrocyte-secreted factor, thrombospondin1 (TSP1) was identified as a key 
mediator of dendritic spine development and is implicated in Down’s syndrome (Garcia et al., 
2010). Similarly to the Rett syndrome studies described above, Wt neurones developed 
abnormal dendritic spine number and density, as well as synaptic defects when cultured with 
astrocytes from Down’s syndrome patients. However, reinstating normal TSP1 levels rescued 
these effects. 
Another example of a neurodevelopmental disorder with astrocyte dysfunction at its 
centre is fragile X syndrome, which entails autistic traits, epilepsy, and motor and cognitive 
impairments (Hagerman and Stafstrom, 2009). In a mouse model of fragile X syndrome, Wt 
astrocytes prevented mutant neurones from developing abnormal dendrites with fewer 
synapses as compared with cultures of only mutant cells (Jacobs and Doering, 2010). 
Astrocyte-related neurodevelopmental diseases also include psychiatric diseases like 
autism and schizophrenia. Autism is partially attributed to abnormal synapse development 
and an imbalance of excitatory / inhibitory connections, and several genes implicated in 
autistic disorders affect synaptogenesis (Walsh et al., 2008). In schizophrenia, dysregulated 
glutamate homeostasis is thought to underlie psychosis, and is accompanied by fewer 
astrocytes that express less glutamate transporter EAAT2 (also known as Glt-1) (Bauer et al., 
2010; Moghaddam and Javitt, 2012). In addition, schizophrenic patients have fewer synaptic 
connections than non-schizophrenic patients (Bennett, 2009; Glantz and Lewis, 2000), 
illustrating that this disorder too has neurodevelopmental features. 
In summary, astrocytic dysfunction is central to many neurodevelopmental diseases: 
For the disorders described above, common symptoms like epileptic seizures and abnormal 
synapse formation and function are all linked to astrocytic dysfunction (Molofsky et al., 
2012). In these cases, the term “neurodevelopmental disease” is misleading, since several 
such conditions have equally central “gliodevelopmental” aspects. Taken together, these 
studies demonstrate that studying astrocytes is not just a matter of understanding brain 
physiology, but also pathology. 





2.3 Astro-neuronal communication and the tripartite 
synapse 
The previous chapters outlined how astrocytes support both neuronal circuit function and 
development. This support is far from passive: Astrocytes actively signal to and receive input 
from neurones (and other glia) via ions (primarily Ca2+ but also Na+ and K+) and molecules 
(e.g. glutamate, ATP). Using these diverse signalling agents, astrocytes influence both 
synaptic signalling and plasticity (Araque and Navarrete, 2010; Fellin et al., 2006a). 
The importance of astrocytes at synapses is mirrored by the number of their peri-
synaptic processes: Each protoplasmic astrocyte contacts ≈100,000 synapses in rodents, and 
up to 2 million synapses in humans (Oberheim et al., 2006). Thus, the idea of “tripartite 
synapses” was introduced (Araque et al., 1999) to stress that synapses include not just pre- 
and postsynaptic neurones, but astrocytic processes, too (Fig. 2). Notably, microglia also 
shape synaptic connections, so that referring to “quad-partite synapses” may be even more 
appropriate (Schafer et al., 2012, 2013). However, the term “tripartite synapse” will be used 




Fig. 2: The tripartite synapse 
A Electron micrograph showing a pre- (green) and a post-synaptic (yellow) neuronal process, 
contacted by an astrocyte (blue). B Scheme (using the same colour code) illustrating that astrocytes 
mediate K
+
 ion homeostasis and are capable of sensing extracellular glutamate (Glu) via Glu 
receptors (both processes can trigger astrocytic Ca
2+
 signalling), and that astrocytes also take up 
glutamate to convert it to glutamine (Gln) as a source for glutamate in neurones. Modified images from 
Eroglu and Barres (Eroglu and Barres, 2010). 





2.3.1 Signalling through ions and Ca2+ activity 
 
Unlike neurones, astrocytes are electrically non-excitable and can’t generate action potentials, 
but rather show a linear relationship between injected current and membrane potentia l 
changes; yet, they also express voltage-dependent ion channels in their processes (Barres, 
1991; Steinhäuser, 1993). Instead of using action potentials to communicate with each other, 
astrocytes employ Ca2+, Na+, and K+ signalling through gap junctions, ion transporters, and 
channels in their membranes (Rose and Karus, 2013; Sontheimer, 1994; Verkhratsky and 
Steinhäuser, 2000). Here, we focus on Ca2+ signalling, which (although intertwined with Na+ 
and K+ ion fluxes) is the major ion-based signalling mechanism in astro-neuronal 
communication. 
 Ca2+ signalling can be observed in cell cultures but also in vivo, where it can occur in 
response to sensory stimulation (Kuga et al., 2011; Wang et al., 2006). Synaptic activity 
locally decreases the extracellular Ca2+ concentration, which in turn triggers glutamate and 
ATP release from astrocytes and subsequent Ca2+ signalling in astrocytes (Torres et al., 2012). 
In addition, astrocytic Ca2+ signalling can also prompt neuronal responses (Nedergaard, 1994; 
Parpura et al., 1994) and thus astrocytes modulate synaptic transmission, e.g. by inhibiting 
(Newman and Zahs, 1998) or increasing electrical activity (Hassinger et al., 1995). At 
synaptic interfaces, their fine, specialised protrusions allow astrocytes to mediate neuronal 
signalling in spatially restricted domains as shown by confocal and electron microscopy 
(Melone et al., 2011; Verkhratsky and Parpura, 2010): Aside from Ca2+ waves, astrocytes also 
exhibit isolated Ca2+ fluctuations in thin processes or even smaller microdomains of around 4 
µm2 (Di Castro et al., 2011; Shigetomi et al., 2013a) (Fig. 3). 
To resolve Ca2+ event dynamics, genetically encoded Ca2+ indicators (GECIs) are a 
new tool that allow for fluorescent visualisation of Ca2+ fluctuations (Kotlikoff, 2007), e.g. 
GCaMP is a circularly permuted GFP variant containing a calmodulin and M13 domain of a 
myosin light chain kinase that fluoresces upon Ca2+ binding (Nakai et al., 2001). Recent 
GCaMP generations like the membrane-tethered Lck-GCaMP3 (Tian et al., 2012) now permit 
imaging Ca2+ events in confined subcellular regions like tripartite synapses and astrocytic 
microdomains (Shigetomi et al., 2010a; Tong et al., 2013).   
 










Fig. 3: Structure and function imply heterogeneity of astrocytic Ca2+ signalling 
Astrocytes show heterogeneous synapse distribution, Ca
2+
 sources and sinks, receptor distribution, 
and Ca
2+
 fluctuations. A Electron micrograph showing heterogeneous synapse (s) distribution where 
each synapse is enwrapped by astrocytic processes (ap). Synapses are enwrapped completely by the 
astrocytic process (s1), only contacted at one side of the synaptic cleft (s2), or not contacted at all 
(s3). B Electron micrograph showing how an astrocytic process contains heterogeneous Ca
2+
 sources 
and sinks, e.g. mitochondria (M) and the endoplasmic reticulum (ER). Other structures include 
mulitvesicular bodies (MVB), vesicular compartments (arrow), and the plasma membrane (PM, white 
dashed line). C Data from Ca
2+
 imaging studies in astrocytic processes showing heterogeneous G 
protein-coupled receptor distribution and downstream Ca
2+
 fluctuations. Left: Two-photon glutamate 
uncaging causes local Ca
2+
 fluctuations (via metabotropic glutamate receptor 5 (mGluR5)) in some 
subdomains (blue traces) of astrocytic processes (white dashed line), but not in other subdomains 
(black traces). Right: STED image showing uneven distribution of puriner gic P2Y1 receptors (red) 
along astrocytic processes (grey scale). Within the same process, two distinct domains respond 
differently to local application of the P2Y1 receptor agonist 2MeSADP (square image and graph 
below). Modified image from (2014). 





Aside from astro-neuronal signalling, astrocytic Ca2+ signals can also arise 
independently of neuronal stimuli; these Ca2+ signals are capable of inducing intracellular 
Ca2+ waves that can spread to neighbouring astrocytes or affect neuronal signalling (Nett et 
al., 2002; Parri et al., 2001). This suggests that astrocytic Ca2+ signalling can occur on a large 
scale but also within specialised domains, either spontaneously, in response to, or leading to 
neuronal stimulation. In terms of bidirectional communication between astrocytes and 
neurones, Ca2+ signalling events are both diverse and specific at once. 
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2.3.2 Signalling through molecules 
 
Apart from Ca2+-mediated signalling, astrocytes and neurones also communicate through 
molecules to a large extent. A major site of molecular signal exchange is the tripartite 
synapse, at which neurones release neurotransmitters (e.g. glutamate). From a metabolic 
perspective, neurotransmitters like glutamate are taken up by astrocytes, where glutamate is 
converted into glutamine and passed to neurones for replenishing synaptic vesicles with 
glutamate. However, astrocytes also express neurotransmitter receptors (e.g. ionotropic and 
metabotropic glutamate, GABA, and purinergic receptors), by which they can sense 
neurotransmitter release from neurones (Verkhratsky, 2009). When neurotransmitters bind to 
their astrocytic receptors, they can elicit intracellular Ca2+ signalling in astrocytes, and via gap 
junctions cause Ca2+ waves in neighbouring glia (Dani et al., 1992; Scemes and Giaume, 
2006). 
In the case of glutamate, it was suggested that astrocytes sense glutamate at synaptic 
interfaces via the metabotropic glutamate receptor (mGluR) 5 (Panatier et al., 2011). 
However, this receptor was recently shown to be expressed only until postnatal week 3, and 
mGluR3 was instead proposed as an astrocytic glutamate sensor due to its developmentally 
unrestricted expression (Sun et al., 2013). This example demonstrates that signalling 
mechanisms between astrocytes and neurones may differ between early postnatal, adolescent, 
and adult cells. 
Another example of how astrocytes respond to neurotransmitter release is that they in 
turn release transmitters (e.g. ATP) themselves and thus modulate synaptic plasticity (Pougnet 
et al., 2014; Zhang et al., 2003). In fact, astrocytes were shown to release several molecules 
that act as transmitters at neuronal synapses; when such chemical signals are released from 
astrocytes (often in a Ca2+-dependent manner), they are referred to as gliotransmitters. 
Gliotransmitter release has received much attention, particularly because of the multitude of 
release mechanisms that are implied, i.e. non-vesicular and vesicular release. This aspect of 
astro-neuronal signalling –gliotransmitters and their release mechanisms– are discussed in 









A true gliotransmitter is defined as any compound that (1) is synthesised or stored in glia, (2) 
is released in a regulated fashion following physiological or pathological stimuli, (3) induces 
fast (millisecond / second) responses in adjacent cells, and (4) has functions in (patho-) 
physiology (Parpura and Zorec, 2010). In astrocytes, the best-studied gliotransmitters include 
glutamate, adenosine triphosphate (ATP), and D-serine, all of which have been proposed to be 
released in a Ca2+-dependent manner (Henneberger et al., 2010; Jacob et al., 2014; Kim et al., 
2015a; Navarrete et al., 2012). Since research on astrocytic gliotransmitters is quite extensive, 
the most prominent examples of gliotransmitter function will be given below to provide an 
overview of how astrocytic compounds affect neuronal network function. 
 One of the first gliotransmitters to be identified was glutamate. Synaptic stimulation 
can elicit astrocytic glutamate release, which in turn modulates synaptic signalling and 
plasticity (Perea et al., 2009; Sasaki et al., 2011). For instance, neuronal activity triggers 
astrocytes to release glutamate, which binds to nearby neuronal N-methyl-D-aspartate 
(NMDA) receptors (Jourdain et al., 2007). As a result, neurotransmitter release probability is 
enhanced, i.e. astrocyte-derived glutamate directly affects synaptic transmission.  
Astrocytes also release ATP into the extracellular space, where ATP is hydro lysed to 
adenosine. Adenosine then inhibits presynaptic neurotransmitter release and thereby 
coordinates neuronal network function (Carlsen and Perrier, 2014; Pascual et al., 2005). 
Further, astrocyte-derived ATP can evoke Ca2+ signals in neighbouring astrocytes, since 
inhibiting ATP receptors or enzymatically degrading ATP led to diminished Ca2+ waves in 
astrocytes (Bowser and Khakh, 2007). 
Astrocytes express high levels of serine racemase, which converts L- to D-serine 
(Schell et al., 1995; Wolosker et al., 1999), which is then released by astrocytes. Similar to 
astrocyte-derived glutamate, D-serine binds to NMDA receptors (Mothet et al., 2000). At 
tripartite synapses, neuronal NMDA currents are amplified when astrocytes continuously 
release D-serine, favouring synaptic potentiation. Astrocytic leaflets tightly ensheath or retract 
from tripartite synapses of the supraoptic nucleus in virgin versus lactating rodents, 
respectively. At these highly dynamic synapses, synaptic depression takes place when 
astrocytic processes are more distant from the synapse – showing a role for astrocyte-derived 
D-serine in metaplasticity (Panatier et al., 2006). 
 In summary, gliotransmitters directly affect synaptic signalling and plasticity (e.g. 
glutamate, D-serine), coordinate synaptic networks (e.g. ATP), and evoke Ca2+ signalling in 
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neighbouring astrocytes (e.g. ATP), which may in turn release other gliotransmitters. 
Astrocytes employ a great diversity of release mechanisms, which can be classified as non-
vesicular or vesicular, as discussed in chapter 2.5. Using several different release mechanisms 
may allow astrocytes to compartmentalise their seemingly contradictory properties (e.g. sinks 
for extracellular neurotransmitters vs. astrocytic glutamate release) via spatial (distinct 
subcellular domain) and temporal specificity (Fields and Stevens-Graham, 2002).  
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2.5 Release mechanisms of astrocytes 
2.5.1 Non-vesicular and vesicular release 
 
Astrocytes employ several distinct release mechanisms (e.g. for gliotransmission), which can 
be divided into non-vesicular and vesicular release. 
 Non-vesicular release in astrocytes entails numerous mechanisms that can broadly be 
categorised into channel-mediated (via cell swelling- induced anion channel opening, 
connexin hemichannels, pannexin channels, and ionotrop ic receptors) and transporter-
mediated release (via reversal of uptake by plasma membrane transporters, antiporters, and 
organic anion transporters). 
Channel-mediated release occurs in response to cell volume changes or ligand binding 
to channel receptors that change the conformation of the channel. Of the three gliotransmitters 
mentioned earlier –glutamate, D-serine, and ATP– cell swelling-regulated anion channels 
were only reported as permeable to glutamate (Kimelberg et al., 1990; Takano et al., 2005). 
Connexin hemichannels (also known as connexons) constitute half of a cell-cell channel, 
while pannexin channels (also known as pannexons) reside within the membrane of a single 
cell (Sosinsky et al., 2011). In contrast to cell swelling-regulated anion channels, connexin 
hemichannels and pannexin channels allow both glutamate (Barbe et al., 2006; Ye et al., 
2003) and ATP (Cotrina et al., 1998, 2000; Dahl, 2015) to pass. Similarly, ionotropic 
purinergic receptors also mediate glutamate (Duan et al., 2003; Fellin et al., 2006b) and ATP 
release from astrocytes (Bowser and Khakh, 2007). 
Transporter-mediated release is a mechanism with bidirectional effects, e.g. as 
glutamate exits the astrocyte through reversal of uptake by plasma membrane transporters, K+ 
enters the cells (Malarkey and Parpura, 2008). Reversal of uptake by plasma membrane 
transporters passage glutamate (Szatkowski et al., 1990; Volterra et al., 1996) and D-serine 
(Ribeiro et al., 2002), but ATP release by this mechanism was not reported. Antiporters in 
astrocytes were only shown to release glutamate (and take up cystine in exchange) (Baker et 
al., 2002; Warr et al., 1999), while organic anion transporters mediate both glutamate 
(Rosenberg et al., 1994) and ATP (Anderson et al., 2004; Queiroz et al., 1999) release. 
Astrocytes likely recruit different release mechanisms according to the type of stimuli 
they receive and the subcellular domain from which substances are released. In support of 
this, a recent study in cultured astrocytes revealed two non-vesicular, channel-mediated types 
of glutamate release, where G-protein coupled receptor activation led to opening of the 
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glutamate-permeable K+ channel Trek-1 (with fast kinetics) or the Ca2+-activated anion 
channel Best1 (with slow kinetics) (Woo et al., 2012). Interestingly, channels mediating fast 
glutamate release (Trek-1) were mostly localised to the cell body and processes, whereas 
channels mediating slower glutamate release (Best1) were mostly localised to astrocytic 
microdomains. 
Numerous studies suggest that in addition to non-vesicular release mechanisms, 
glutamate, ATP, and D-serine can also be exocytosed via vesicles in a Ca2+-dependent 
manner. Three classes of vesicles were found in astrocytes: lysosomes (Jaiswal et al., 2007; Li 
et al., 2008; Zhang et al., 2007), large dense-core vesicles / secretory granules (Coco et al., 
2003; Prada et al., 2011; Ramamoorthy and Whim, 2008), and small synaptic- like 
microvesicles (Bergersen and Gundersen, 2009; Bergersen et al., 2012; Bezzi et al., 2004; 
Jourdain et al., 2007; Martineau et al., 2013). These and other astrocytic organelles (including 
recycling endosomes) are summarised in Fig. 4. 
In contrast to non-vesicular mechanisms, vesicular release from astrocytes requires 
vesicular organelles to transport cargo (e.g. gliotransmitters) to the cell membrane and 
undergo Ca2+-dependent exocytosis. On a molecular level, vesicle fusion is mediated by 
vesicle-associated proteins, which are examined in more detail in chapter 2.6. Thus, three 
hallmarks of vesicle exocytosis are vesicular organelles, Ca2+ dependency, and vesicle-
associated proteins capable of affecting vesicle fusion. 





Much of the initial support for vesicular exocytosis has come from astrocyte 
monocultures, which meet these three criteria: They express several vesicle-associated 
proteins (Montana et al., 2006; Parpura and Zorec, 2010), contain vesicular organelles with 
diameters similar to synaptic and dense-core vesicles / secretory granules (Martineau et al., 
2013; Singh et al., 2014), and release gliotransmitters like glutamate in a Ca2+-dependent 
manner (Bezzi et al., 1998; Innocenti et al., 2000; Pasti et al., 2001; Zhang et al., 2004a). 
Similar observations were made in brain slices and in vivo, where astrocytes too express 
vesicle-associated proteins or their mRNA (Mittelsteadt et al., 2009; Schubert et al., 2011), 
feature vesicular organelles (Hur et al., 2010; Williams et al., 2006), and show Ca2+-
dependent gliotransmitter release (Kang et al., 2013; Rossi et al., 2000). Thus, whether or not 
 
Fig. 4: Vesicle subtypes of membrane trafficking 
Schematic diagram showing different vesicle subtypes and their respective vesicle-associated 
membrane proteins (VAMPs), i.e. synaptic vesicles (SV, comparable to small synaptic -like 
microvesicles in astrocytes), secretory granules (SG), recycling endosomes (RE), early (EE) and late 
(LE) endosomes, and lysosomes (Lyso). Vesicle diameter can range from 30-50 nm (SVs), ≈300 nm 
(SG), 60-2000 nm (RE), and 60-3000 nm (LE and Lyso). Example transmitters include glutamate 
(Glu), ATP, and D-serine (D-ser). Image taken from Hamilton and Attwell (2010). 
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astrocytes employ release through vesicles in general is no longer a question – but if these 
vesicles undergo regulated release, and if so, what the underlying molecular mechanisms, 
vesicle subtypes, and cargo are, is a matter of debate. 
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2.5.2 Studying gliotransmitter release: Astrocyte culture systems 
 
A lot of what we know about gliotransmitter release from astrocytes has come from cell 
culture systems. Although in vivo experiments are superior to cell cultures by physiological 
parameters, cell culture experiments give access to experimental manipulations that can help 
dissect molecular mechanisms within living cells. Since astrocytes share a lot of the same 
transmitter molecules and receptors with neurones, molecules present in astrocytic versus 
neuronal processes (that are closely connected) are difficult to distinguish in co-cultures of 
astrocytes and neurones. Although fluorescence-activated cell sorting (FACS) can be used to 
reliably isolate astrocytes (Dutly and Schwab, 1991; Foo, 2013a; Sergent-Tanguy et al., 
2003), this method identifies cells by GFP expression (e.g. under the control of an astrocyte-
specific promoter, which may not be expressed in all astrocytes) and restrains cell health so 
that cell cultures are difficult to maintain (Foo, 2013a). 
To study gliotransmitter release in astrocytes isolated from neurones, a p rotocol for 
growing so-called “MD” astrocyte monocultures was developed 35 years ago that has led to 
numerous advances in the astrocyte field (McCarthy and de Vellis, 1980). Since then, several 
other monoculture protocols have been designed aimed at culturing more physiologically 
relevant astrocytes. The four major approaches to date are listed below and include MD 
astrocytes, immunopanned (IP) astrocytes, astrocytes derived from induced pluripotent stem 
cells (iPSCs), and astrocytes grown in 3D matrices (Table 1). 
 
Table 1: Common and recently developed astrocyte monoculture protocols 
Comparison of the commonly used MD culture method with three recently published protocols, listing 
advantages and disadvantages of each protocol, as well as the cell source and the original reference.  
 
Culture method Cell source Advantages Potential disadvantages 
MD 




simple, quick, cheap 
polygonal morphology, protein expression 
profile unlike freshly isolated astrocytes 
(Foo et al., 2011), uses serum 
IP 
(Foo et al., 2011) 
P0-14 
stellate morphology, gene expression 
like freshly isolated astrocytes, serum-
free 
lengthy protocol, requires many reagents 
iPSC-derived 
(Krencik & Zhang, 2011) 
iPSCs 
human astrocytes, can use cells from 
“disease-specif ic tissue”, maintain for 
months, serum-free 
takes more than 3 months to prepare (and 
longer to mature) 
3D matrix 
(Puschmann et al., 2013; 
Placone et al., 2015*) 
P1-3 
stellate, 3D morphology, serum-free*, 
murine/human 
requires 3D matrices 
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 The central steps of the MD method are culturing cells in serum-containing 
Dulbecco’s Modified Eagle Medium (DMEM), and shaking them after 7-10 days in culture. 
At this point, neurones and all non-astrocytic glia detach from the culture dish, so that only 
astrocytes remain after shaking. MD astrocytes develop a polygonal (not stellate as in vivo) 
morphology, and express high Gfap levels (a sign of pathology in brain regions like the cortex 
(Zamanian et al., 2012)). Simply growing cells in the same medium (without shaking) also 
yields polygonal, non-neuronal cells that express predominantly astrocyte markers like Gfap, 
Aldh1L1, and Vimentin (Du et al., 2010; Souza et al., 2013). This suggests that much of the 
differentiation into polygonal astrocytes may be due to medium composition, and not due to 
preparation methods (i.e. shaking to remove other cell types). 
 In contrast to MD astrocytes, IP astrocytes morphologically resemble astrocytes in 
vivo, although the protocol to generate IP astrocytes is long, requires many reagents, and 
yields only few cells (Foo et al., 2011). Other drawbacks include that astrocytes are selected 
by a single astrocyte-specific cell surface antibody, possibly selecting for just a subset of 
astrocytes (since no common astrocyte marker exists) and are kept at room temperature for 
hours during immunopanning (Fig. 5), which may compromise cell viability. Compared with 
MD astrocytes, most cortical IP astrocytes express similar Gfap levels, suggesting that 
although IP astrocytes are more in vivo-like in terms of morphology, they may still represent 
reactive astrocytes.  
 
 
Fig. 5: Immunopanning steps for isolating astrocytes 
For generating immunopanned (IP) astrocytes, a cell suspension is prepared from early postnatal rats 
or mice, which is subjected to a series of negative and one final positive immunopanning step to 
isolate astrocytes. Above each dish, the targeted cell type is noted, while the respective probes 
attached to the dish surfaces are indicated below each dish. In each step, different cell types are 
selected for by first a secondary (2º) antibody only to target non -specific binding of mostly immune-
responsive cells, then by BSL-1 (a bacterial lectin to target microglia and macrophages) and 
antibodies against CD45, O4, and finally ITGB5. Modified from Foo et al. (2011). 
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Another difference between MD and IP astrocytes is the medium, i.e. serum-
containing DMEM versus a serum-free mix of DMEM and Neurobasal medium that includes 
the heparin-binding EGF-like growth factor (HBEGF). While HBEGF is expressed in the 
brain from embryonic day 14 onwards (and is upregulated during astrogliogenesis), HBEGF 
promotes astrocyte migration (Faber-Elman et al., 1996) and proliferation in culture 
(Kornblum et al., 1999). Hence, HBEGF may support astrocyte survival, proliferation, and/ or 
differentiation (Puschmann et al., 2013) – which would be reflected in astrocyte morphology 
and behaviour. 
 These attributes of HBEGF were recently incorporated in a protocol for growing 3D 
astrocyte monocultures (Puschmann et al., 2013). Apart from promoting an in vivo-like 
morphology of astrocytes, HBEGF quality is consistent (unlike serum, which is prone to 
varying batch quality), resulting in more consistent cultures, while still enhancing astrocyte 
proliferation as much as serum (Puschmann et al., 2014). However, some cell culture 
techniques benefit from 2D cell cultures, e.g. imaging Ca2+ signalling within processes of one 
or several astrocytes or total internal reflection fluorescence microscopy, which is only 
possible within a single optical plane. 
 Using a protocol beginning with iPSCs, human astrocytes can be generated, matured, 
and maintained in serum-free medium with a combination of growth factors (Krencik and 
Zhang, 2011). Like IP astrocytes, these iPSC-derived astrocytes are also Gfap-positive and 
may thus represent reactive astrocytes. 
 Protocols for 3D astrocyte monocultures demonstrate that non-reactive astrocytes 
(which only express little Gfap and Vimentin) can be cultured. And protocols using different 
medium for cultured astrocytes suggest that chemically defined media including HBEGF are 
superior to serum-containing media not just by ensuring quality standards, but also by 
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2.6 Vesicle-associated proteins in astrocytes 
Astrocytes express several vesicle-associated proteins that are implicated in vesicular fusion 
in other cells, e.g. synaptic vesicle fusion in neurones. Vesicle-associated proteins can refer to 
proteins integral to or associated with membranes of exocytotic vesicles (e.g. lysosomes, 
dense-core vesicles / secretory granules, small synaptic- like microvesicles, or recycling 
endosomes), or endocytotic vesicles (e.g. early or late endosomes). 
 
 
2.6.1 SNARE proteins in astrocytes 
 
Every cell expresses soluble NSF attachment protein receptor (SNARE) proteins, which are 
involved in intracellular membrane trafficking (Jahn and Scheller, 2006), and mediate 
docking and fusion of vesicles with their respective target membranes. SNARE proteins are 
required for endocytotic (Deák et al., 2004) and exocytotic vesicle fusion, and have been 
studied extensively in the context of neuronal synaptic vesicle exocytosis. During synaptic 
transmission, an incoming action potential causes voltage-gated Ca2+ channels in the axon 
terminal to open, so that intracellular [Ca2+] increases. As a result, synaptic vesicles fuse with 
the pre-synaptic plasma membrane; the SNARE complex orchestrates this fusion. Four 
proteins (one vesicular SNARE, Vamp2 (also known as synaptobrevin), the plasma 
membrane protein syntaxin1, and two copies of the plasma membrane associated protein 
Snap25 (a target SNARE) make up the SNARE complex (Fig. 6) which promotes fusion. The 
Ca2+ sensor synaptotagmin (Syt) 1 triggers fast synchronous fusion in response to Ca2+-
binding to its two C2 domains, which causes it to bind tightly to SNARE proteins and to 
insert into lipid bilayers (Chapman, 2002).  
 





Some of these fusion-related proteins also exist in astrocytes. Astrocytes express not 
only Vamp2 (and Vamp3 or cellubrevin), but also syntaxin isoforms 1, 2, 3, and 4 (Bal-Price 
et al., 2002; Jeftinija et al., 1997; Paco et al., 2009; Tao-Cheng et al., 2015), Snap23, and Syt 
isoforms 4, 7, and 11 – thus, astrocytes may release gliotransmitters via exocytotic vesicles in 
a similar manner to neurones (Hamilton and Attwell, 2010; Volknandt, 2002). 
The majority of studies reporting the presence of SNARE proteins in astrocytes have 
used cultured astrocytes (Montana et al., 2006), and reports have been conflicting (e.g. Syt1 
and the pre-synaptic vesicle protein synaptophysin (Syp) were both detected in astrocytes by 
immunostainings (Maienschein et al., 1999), but were not found in subsequent studies (Fiacco 
et al., 2009)). The presence of only few SNAREs, e.g. Vamp2 (Zhang et al., 2004b) and 
Vamp3 (Bezzi et al., 2004; Wilhelm et al., 2004), were confirmed by experiments in slices or 
in vivo. 
 
Fig. 6: SNARE proteins involved in vesicle fusion with the plasma membrane 
Synaptic vesicles fuse with the cell membrane via the SNARE proteins synaptobrevin / Vamp2, 
syntaxin, and Snap25 (SNAP-25). Synaptotagmin is associated with the vesicular membrane via its 
helical transmembrane domain. When the intracellular Ca
2+
 concentration rises due to an incoming 
action potential, Ca
2+
 binds to the C2 domains of synaptotagmin, causing conformational changes that 
lead to partial insertion of synaptotagmin into the plasma membrane, and the SNARE complex 
promotes fusion of the vesicle and plasma membranes, causing vesicle cargo to be released into the 
extracellular space. Modified image from Chapman (2002). 
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Functional studies illustrate that vesicle-dependent exocytotic release from astrocytes 
likely involves several SNARE proteins (Jeftinija et al., 1997; Parpura et al., 1995; Verderio 
et al., 1999). For instance, cleaving syntaxin1 with botulinum toxin C leads to reduced 
glutamate baseline and evoked glutamate release (Bal-Price et al., 2002; Jeftinija et al., 1997). 
The release of another gliotransmitter, D-serine, is strongly reduced when blocking Vamp2 
and 3 function by tetanus toxin (Mothet et al., 2005).  
Moreover, overexpressing a dominant-negative domain of vesicular SNARE 
(dnSNARE) showed that inhibiting SNARE complex formation also decreases astrocytic 
glutamate release in astrocytes of the transgenic dnSNARE mouse model (Pascual et al., 
2005; Zhang et al., 2004b). In dnSNARE mice, astrocyte-derived adenosine (hydrolysed from 
ATP) was identified as a key gliotransmitter for regulating neuronal circuits (Fellin et al., 
2009). 
 The majority of evidence to date suggests that astrocytes most likely do express 
SNARE proteins, but how these proteins co-operate to potentially regulate fusion, and which 
vesicles they localise to is less well understood, possibly because of variable results from cell 
culture and in situ studies (Montana et al., 2006; Schubert et al., 2011). Interestingly, 
astrocytes express several Syt isoforms (in cultures, slices, and in vivo), suggesting that they 
may regulate exocytosis of gliotransmitters or other substances.   
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2.6.2 Synaptotagmins in astrocytes 
 
The Syt isoforms are central mediators of vesicular exocytosis, of which Syt1, 4, and 7 are 
evolutionarily conserved (Andrews and Chakrabarti, 2005). All Syt isoforms contain C2 
domains, and with the exception of Syt17, all Syts have a helical transmembrane domain by 
which they are incorporated into membranes (Fig. 7).  
 
 
Regulated synaptic vesicle exocytosis in neurones occurs in response to local Ca2+ 
rises, which are detected by the Ca2+ sensor Syt1. In vitro fusion assays revealed that only 
some Syts trigger Ca2+-dependent vesicle fusion (e.g. Syt1 and 7) while others (e.g. Syt4, 8, 
11, and 12) act as inhibitors of vesicle fusion (Bhalla et al., 2008; Dean et al., 2009; Potokar 
et al., 2008). 
In astrocytes, which feature large intracellular Ca2+ fluctuations, vesicle fusion may 
also be regulated by Ca2+-sensing via Syts. Although astrocytes do not express Syt1, there are 
other candidates: Astrocytes express the mRNA of Syt4, 7, and 11 (and low levels of Syt5 
mRNA) in vivo (Cahoy et al., 2008; Mittelsteadt et al., 2009). Syt isoform proteins were 
further detected in astrocytes, including Syt4 (Malarkey and Parpura, 2011) and Syt17 
(Camin Dean, unpublished data). The 17 known mammalian Syt isoforms are structurally and 
functionally distinct (Bhalla et al., 2008; Hui et al., 2005), which favours the idea that Syts 
may affect several different intracellular membrane trafficking pathways and thus localise to 
different vesicle subtypes (Schiavo et al., 1998; Südhof, 2002). 
Syt4 was reported to mediate astrocytic glutamate release, since Syt4 knockdown 
experiments in astrocytes led to less Ca2+-dependent glutamate release from astrocytes (Zhang 
 
Fig. 7: Simplified Syt structure 
Syts contain Ca
2+
-binding C2 domains, which in some Syts (e.g. 1, 2, 3, 4, 6, 7, 9, and 10) allow Ca
2+
-
sensing. Syts are incorporated into membranes via a helical transmembrane domain (except for 
Syt17, which lacks this domain), thus exposing their N terminus to the lumen of vesicles.  
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et al., 2004a). Syt4-/- mice exhibit altered hippocampal function and memory deficits 
(Ferguson et al., 2004a, 2004b), implying that Ca2+-dependent glutamate release by astrocytes 
may contribute to learning and memory.  
 Syt7 shows the highest Ca2+-binding affinity of the Syt isoforms (Hui et al., 2005). 
Syt7 is mostly associated with lysosomes in cultured neurones, fibroblasts, and macrophages 
(Arantes and Andrews, 2006; Flannery et al., 2010; Martinez et al., 2000). In neuroendocrine 
cells, Syt7 was found on large dense-core vesicles / secretory granules, where it mediates 
Ca2+-dependent exocytosis of these vesicles (Fukuda et al., 2004; Wang et al., 2005), although 
a later study reported that Syt7 is on endosomal but not large dense-core vesicles of endocrine 
and neuroendocrine cells (Monterrat et al., 2007). Revealing yet another potential site of 
action, Syt7 was recently reported to mediate synaptic vesicle replenishment in neurones (Liu 
et al., 2014).  
 Compared with Syt4 and 7, much less is known about Syt11 and 17. In macrophages, 
Syt11 acts as a negative regulator of tumor necrosis factor and interleukin-6 secretion, and 
associates with recycling endosomes, lysosomes, and even phagosomes (Arango Duque et al., 
2013). Since Syt17 lacks a transmembrane domain, it is not always considered a “true” Syt, 
although Syt17 contains C2 domains and is vesicle-associated (Takamori et al., 2006). Syt17 
is also referred to as B/K protein, and was detected within membranes of the trans-Golgi 
network, which is the cell’s centre for lysosomal and secretory vesicle assembly (Fukuda and 
Mikoshiba, 2001a). 
 Only little is known about astrocytic Syt isoforms, and the vesicles they are associated 
with, and how and if they are relevant for vesicle recycling is unknown. Unlike other vesicle-
associated proteins, whose presence in astrocytes in vivo is under debate, Syt mRNA was 
clearly linked to astrocytes, suggesting that some Syts are involved in astrocytic vesicle 
trafficking and / or fusion. 
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2.7 Aim of the project 
Astrocytes represent the glial cell type with the most diverse functions, many of which require 
that astrocytes release molecules like gliotransmitters (to mediate synaptic signalling and 
plasticity) or synaptogenic factors (to shape developmental processes). Astrocyte dysfunction 
underlies many common neurodevelopmental disorders, e.g. epilepsy and Down’s syndrome. 
In both health and disease, astrocytes are closely connected to neurones by structure and 
function, and astrocytes and neurones communicate reciprocally, e.g. at tripartite synapses. 
To ensure normal brain function, astrocytes employ many different release 
mechanisms, with evidence for non-vesicular (through channels and transporters) and 
vesicular release (through lysosomes, dense-core vesicles, or small synaptic- like 
microvesicles). Astrocytes contain vesicular organelles that correspond to all exocytotic 
vesicle types by size, express several vesicle-associated proteins implicated in vesicle fusion, 
and release gliotransmitters in a Ca2+- and SNARE protein-dependent manner (Montana et al., 
2006). Nonetheless, regulated vesicular exocytosis in astrocytes is under debate (Fiacco et al., 
2009; Martineau, 2013; Sloan and Barres, 2014b; Vardjan and Zorec, 2015), in part because 
much of the evidence for this mechanism comes from cell culture studies of polygonal, 
reactive astrocytes. 
The purpose of this project was to analyse candidate molecules involved in astrocytic 
vesicle fusion (i.e. Vamp2 and different Syt isoforms), their role in vesicle recycling, and 
effects of specific glial compounds released at synaptic interfaces. Thus, we aimed to 
contribute to a better understanding of molecular mechanisms of astrocytic release, and their 
role in synaptic function. To analyse the presence of candidate vesicle-associated proteins 
involved in astrocytic vesicle fusion, we developed a simple protocol for growing stellate, 
more “in vivo-like” astrocyte monocultures. Further, distinct types of astrocytic Ca2+ events 
(as required for regulated vesicular release) were observed in different subcellular domains in 
these stellate cultured astrocytes, as observed in brain slices and in vivo (Shigetomi et al., 
2013a; Srinivasan et al., 2015). 
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3.1.1.1 Antibodies for immunopanning astrocytes 
 
The following primary antibodies were used for the immunopanning protocol: 
anti-mouse CD45 (BD Biosciences Pharmingen, 550539) 
anti-O4 (Millipore, MAB345) 
anti-human integrin beta 5 (eBioscience, 14-0497-82) 
 
The following secondary antibodies were used for the immunopanning protocol: 
goat anti-mouse IgG+IgM (H+L) (Jackson ImmunoResearch, 115-005-044) 
goat anti-mouse IgM µ-chain specific (Jackson ImmunoResearch, 115-005-020) 
goat anti-rat IgG H+L (Jackson ImmunoResearch, 112-005-167) 
 
3.1.1.2 Antibodies for immunostainings 
 
The following primary antibodies were used for immunocytochemistry and 
immunohistochemistry: 
mouse anti-ALDH1L1 (NeuroMab, cat. no.: 75164) 
rabbit anti-EEA1, diluted 1:500 (Snaptic Systems, cat. no.: 237002) 
guinea pig anti-GFAP, diluted 1:1000 (Synaptic Systems, cat. no.: 173005) 
mouse anti-GFP, diluted 1:2000 (Abcam, cat. no.: ab1218) 
rabbit anti-GFP, diluted 1:2000 (Abcam, cat. no.: ab290) 
chick anti-GFP, diluted 1:2000 (Abcam, cat. no.: ab13970) 
goat anti-Hevin, diluted 1:1000 (R&D Systems, cat. no.: AF2836) 
chick anti-Map2, diluted 1:5000 (Biosensis, cat. no.: C-1382-50) 
rabbit anti-Rab7, diluted 1:500 (Abcam, cat. no.: ab74906) 
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guinea pig anti-synaptophysin, diluted 1:1000 (Synaptic Systems, cat. no.: 101004) 
mouse anti-Syt1, diluted 1:2000 (Synaptic Systems, cat. no.: 105101) 
guinea pig anti-Syt1, diluted 1:2000 (Synaptic Systems, cat. no.: 105105) 
rabbit anti-Syt4, diluted 1:500 (Synaptic Systems, cat. no.: 105043) 
mouse anti-Syt7, diluted 1:500 (NeuroMab, cat. no.: 75-265) 
rabbit anti-Syt7, diluted 1:200 (Synaptic Systems, cat. no.: 105173) 
mouse Syt11, diluted 1:500 (Abnova, cat. no.: h00023208-m03) 
rabbit anti-Syt17, diluted 1:2000 (Abcam, cat. no.: ab76274) 
mouse anti-βIII-tubulin, diluted 1:100 (Abcam, cat. no.: ab78078) 
rabbit anti-Vamp2, diluted 1:1000 (Synaptic Systems, cat. no.: 104202) 
guinea pig anti-Vamp2, diluted 1:500 (Synaptic Systems, cat. no.: 104204) 
 
The following secondary antibodies were used for immunocytochemistry and 
immunohistochemistry: 
donkey anti-goat Alexa488, diluted 1:1000 (Invitrogen, cat. no.: A-11055) 
donkey anti-mouse Alexa488, diluted 1:1000 (Invitrogen, cat. no.: A-21202) 
goat anti-rabbit Alexa488, diluted 1:1000 (Invitrogen, cat. no.: A-11008) 
 
goat anti-guinea pig Alexa546, diluted 1:2000 (Invitrogen, cat. no.: A-11074) 
goat anti-rabbit Alexa546, diluted 1:2000 (Invitrogen, cat. no.: A-11010) 
 
goat anti-guinea pig Alexa647, diluted 1:1000 (Invitrogen, cat. no.: A-21450) 
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3.1.1.3 Antibodies for immunoblotting 
 
The following primary antibodies were used: 
mouse anti-Aldh1L1, diluted 1:500 (NeuroMab, cat. no.: 75140) 
mouse anti-Cd11b, diluted 1:200 (Abcam, cat. no.: ab8879) 
mouse anti-GAPDH, diluted 1:1000 (Enzo Life Sciences, cat. no.: 11101127) 
guinea pig anti-GFAP, diluted 1:1000 (Synaptic Systems, cat. no.: 173005) 
goat anti-glypican6, diluted 1:2000 (R&D Systems, cat. no.: AF1053) 
goat anti-Hevin, diluted 1:2000 (R&D Systems, cat. no.: AF2836) 
chick anti-Mbp, diluted 1:2000 (Abcam, cat. no.: ab106583) 
mouse anti-Nestin, diluted 1:1000 (Synaptic Systems, cat. no.: 312011) 
mouse anti-Rab3a, diluted 1:2000 (Synaptic Systems, cat. no.: 107111) 
mouse anti-S100β, diluted 1:200 (Abcam, cat. no.: ab4066) 
mouse anti-Snap25, diluted 1:1000 (Synaptic Systems, cat. no.: 111011) 
mouse anti-synaptophysin, diluted 1:2000 (Millipore, cat. no.: mab368) 
mouse anti-Syt1, diluted 1:2000 (Synaptic Systems, cat. no.: 105101) 
mouse anti-Syt3, diluted 1:1000 (NeuroMab, cat. no.: 75-269) 
rabbit anti-Syt4, diluted 1:1000 (Synaptic Systems, cat. no.: 105043) 
rabbit anti-Syt5, diluted 1:500 (Synaptic Systems, cat. no.: 105053) 
rabbit anti-Syt7, diluted 1:1000 (Synaptic Systems, cat. no.: 105173) 
mouse anti-Syt11, diluted 1:500 (Abnova, cat. no.: h00023208-m03) 
rabbit anti-Syt17, diluted 1:1000 (Abcam, cat. no.: ab76274) 
mouse anti-syntaxin1, diluted 1:2000 (Synaptic Systems, cat. no.: 110011) 
goat anti-thrombospondin1, diluted 1:400 (R&D Systems, cat. no.: AF3074) 
guinea pig anti-Vamp2, diluted 1:2000 (Synaptic Systems, cat. no.: 104204) 
rabbit anti-Vamp4, diluted 1:100 (Synaptic Systems, cat. no.: 136002) 
rabbit anti-vGluT1, diluted 1:1000 (Synaptic Systems, cat. no.: 135303) 
guinea pig anti-vGluT2, diluted 1:1000 (Synaptic Systems, cat. no.: 135404) 
rabbit anti-vGluT3, diluted 1:2000 (Synaptic Systems, cat. no.: 135203) 
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The following secondary antibodies were used: 
HRP-coupled monoclonal mouse antibody, diluted 1:2000 (Bio-Rad, cat. no.: 1706516) 
HRP-coupled rabbit polyclonal antibody, diluted 1:2000 (Bio-Rad, cat. no.: 1706515) 
HRP-coupled guinea pig polyclonal antibody, diluted 1:5000 (Abcam, cat. no.: ab97155) 
HRP-coupled goat polyclonal antibody, diluted 1:5000 (Abcam, cat. no.: ab6741) 
 




All animals used for experiments in this dissertation were bred and kept in the mouse facility 
of the European Neuroscience Institute or the animal facility of the University Medical Center 
in Göttingen, Germany. All experiments were performed in accordance with the guidelines 
for German animal welfare. All animals were euthanised by CO2. 
 
3.1.2.1 Mouse lines 
 
Wild-type C57B6/J mice were used for histological analysis and brain lysate preparation for 
immunoblots, while Syt7+/+ or Syt7-/- mice were used for tissue culture preparations. 
 
3.1.2.2 Mouse tail biopsy and PCR 
 
Mouse tail biopsies were prepared by digesting tails with 7 µl 10 mg/ml proteinase K in 500 
µl lysis buffer (100 mM Tris-HCl (pH 8.5), 5 mM EDTA (pH 8.0), 0.2% SDS, 200 mM 
NaCl) while shaking for 6 hrs or overnight at 55 ºC. Subsequently, samples were centrifuged 
in tabletop centrifuges at maximum speed for 10 min. For each sample, the resulting 
supernatant was transferred to a fresh eppendorf tube and precipitated with 500 µl ispropanol 
and mixed well. Samples were then centrifuged again at maximum speed for 10 min, after 
which the supernatants were removed and 200 µl 70% ethanol were used to wash each pellet 
by centrifuging for another 10 min at maximum speed. Next, the ethanol was removed and the 
pellets dried for subsequent resuspension in 100 µl ddH2O.  
 For each sample, 2 µl DNA were transferred to fresh PCR tubes, and mixed with 48 µl 
of the following PCR mix: 
 
for one PCR sample: 
5 µl 10 X buffer 
0.4 µl 25 mM dNTPs 
1 µl 10 µM forward primer 
1 µl 10 µM reverse primer 
0.25 µl Taq DNA polymerase 
40.25 µl dH2O 
48 µl total / reaction (+ 2 µl DNA) 
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Samples were then placed in thermocyclers for the PCR to amplify specific DNA segments 
(Mullis et al., 1986; Saiki et al., 1988). 
 
To separate the PCR products, 2% (w/v) agarose gels in 1X TAE buffer (including SYBR® 
Safe DNA Gel Stain, ThermoFisher Scientific) were loaded with PCR samples and 100 bp 
DNA ladder (ThermoFisher Scientific, Germany) in a separate lane. DNA bands were 
separated by horizontal gel electrophoresis at 75 V for 1 h. To document genotyping results, 
pictures were obtained using a UV illuminator with the INTAS imaging system. 





3.2.1 Cell culture 
 
The following types of cortical cultures were prepared: Co-cultures of neurones and glia, 
astroglial-enriched cultures using the MD method (McCarthy and de Vellis, 1980), the NB+H 
protocol explained below, or immunopanning (IP) astrocytes (Foo, 2013b; Foo et al., 2011). 
 
3.2.1.1 Preparing cultures from E19 rat cortices 
 
Co-cultures, MD, and NB+H (but not IP) astrocytes were prepared from E19 Wistar rat pups 
by standard cell culture preparations (Dichter, 1978; McCarthy and de Vellis, 1980) with 
minor modifications. Pregnant rats were euthanised by CO2 so that rat pups could be removed 
from the uterus. The embryonic sacs were opened, the pup heads cut off with scissors, and the 
heads were placed in 4 ºC cold dissection medium (10 mM HEPES (Gibco, cat. no.: 
15630080) in Hank’s Balanced Salt Solution (Gibco, cat. no.: 14170112)). Next, brains were 
isolated, their meninges removed, and the cortices isolated, cut into small pieces and collected 
in a tube filled with 4 ºC cold dissection medium. Cortex pieces were incubated in 0.25 % 
trypsin-EDTA (Gibco, cat. no.: 25200056) in a 37 ºC waterbath. After 20 min, trypsin-EDTA 
was removed and the tissue was washed in 4 ºC dissection medium three times. After the last 
washing step the tissue was triturated by pipetting up and down in 1 ml NB+ (2% B27 
supplement (Gibco, cat. no.: 17504044), 2 mM Glutamax (Gibco, cat. no.: 35050061), 5000 
U/ml penicillin and 5000 µg/ml streptomycin (Gibco, cat. no.: 15070063) in Neurobasal 
medium (Gibco, cat. no.: 21103049)). The cell suspension was then filtered through a 100 µm 
nylon cell strainer (BD Biosciences, cat. no.: 352360), pre-wet with 4.5 ml NB+. Next, 
another 4.5 ml NB+ were added to wash out cells stuck to the cell strainer. Using the Trypan 
Blue (Sigma, cat. no.: T8154) exclusion technique, cells were counted and plated on cell 
culture dishes pre-equilibrated with medium in a Hera Cell 240i cell culture incubator 
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3.2.1.2 Co-cultures of neurones and glia 
 
Co-cultures were plated at a density of 50,000 cells / well on 12 mm glass coverslips pre-
equilibrated with NB+ in the incubator (or 2x106 cells/dish for generating samples for 
Western blots). All glass coverslips and 10 cm dishes were coated with 0.04% PEI in ddH2O 
for 24 hrs, then washed twice with ddH2O prior to adding medium / cells. Cell cultures were 
then maintained in the incubator. 
 In addition to E19-derived rat co-cultures, P0-derived mouse co-cultures were also 
prepared from C57B6/J wild-type (Wt) or Syt7-/- mice: For Fig. 22, Wt rat neurones were 
plated onto  day in vitro (DIV) 7 mouse Syt7-/- astrocytes (generated using the MD method 
described below). To control for this difference in species (which may otherwise contribute to 
the effect we saw), we also prepared rat neurones plated onto DIV7 Wt mouse astrocytes. 
However, co-cultures of mouse neurones plated onto DIV7 mouse astrocytes would serve 
validate our findings. 
 
3.2.1.3 MD and NB+H astrocyte monocultures 
 
For MD and NB+H astrocyte monocultures, cells were plated in DMEM+ (10% FCS 
(Invitrogen, cat. no.: 10500064), 5000 U/ml penicillin, 5000 µg/ml streptomycin in DMEM 
(Gibco, cat. no.: 41966029)). These cultures were exclusively plated at a density of 500,000 
cells / 10 cm dish, and passaged on day in vitro (DIV) 7. 
On DIV7, 10 cm dishes were placed on a shaker (Heidolph Rotamax 120) within the 
incubator and shaken at 110 rpm for 6 hrs. After shaking, the medium (including loosened 
neurones and non-astrocytic glia) was exchanged with pre-heated 1X PBS, which was then 
replaced by 37 ºC warm 0.25% trypsin-EDTA. Astrocytes were then incubated in the 
incubator in trypsin for 5 min. Next, 5 ml DMEM+ were added to inactivate the trypsin. Cells 
were loosened by forcefully pipetting them off the dish and transferred to a 50 ml Falcon 
tube. Cell suspensions were then centrifuged in an eppendorf centrifuge 5810 R at 4,000 rpm 
(3,220 x g) for 4 min at 20 ºC. The supernatant was then removed and the pellet was re-
suspended in 10 ml DMEM+ for MD astrocytes, or NB+ containing 5 ng/ml heparin-binding 
epidermal growth factor (HBEGF; Sigma, cat. no.: 4643) for NB+H astrocytes. Cells were 
plated at a density of 5,000 cells / well on 12 mm glass coverslips (PEI-coated as described 
above for plating co-cultures). Astroglial-enriched cultures were then maintained in the 
incubator, and half the medium was exchanged once a week. 
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3.2.1.4 Immunopanning astrocytes 
 
Astrocyte monocultures were also generated by immunopanning (IP) (Foo et al., 2011). We 




Griffonia simplicifolia lectin BSL-1 (Vector Labs, cat. no.: L-1100); 20 mg/ml in 1X PBS 
0.4% DNase, 12,500 units/ml (Worthington, cat. no.: LS002007) 
1X Earle’s Balanced Salt Solution (Sigma, cat. no.: E6267) 
50 mM Tris-HCl pH 9.5, sterilised 
Dulbecco’s Modified Eagle Medium (DMEM, Gibco, cat. no.: 41966029) 
fetal calf serum (FCS, Gibco, cat. no.: 10437-028) 
heparin-binding epidermal growth factor (HBEGF, Sigma, cat. no.: 4643) 
L-cysteine hydrochloride monohydrate (Sigma, cat. no.: C7880) 
Neurobasal medium (Gibco, cat. no.: 21103-049) 
papain (Worthington, cat. no.: LS 03126) 
penicillin/streptomycin (Gibco, cat. no.: 15070063)  





BSA (Sigma, cat. no.: A8806) 
trypsin inhibitor (Worthington, cat. no.: LS003086) 
transferrin (Sigma, cat. no.: T-1147) 
putrescine (Sigma, cat. no.: P5780) 
progesterone (Sigma, cat. no.: P8783)   
sodium selenite (Sigma, cat. no.: S5261) 
sodium pyruvate 
L-glutamine 
N-acetyl cysteine (Sigma, cat. no.: A8199) 
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The following solutions were prepared before immunopanning: 
 
Enzyme stock solution (200 ml) 
10X EBSS (E7510)  20 ml  (final conc. 1X) 
30% D(+)-glucose  2.4 ml  (final conc. 0.46%) 
1 M NaHCO3   5.2 ml  (final conc. 26 mM) 
50 mM EDTA   2 ml  (final conc. 0.5 mM) 
ddH2O    170.4 ml 
brought to 200 ml with ddH2O and filtered through 0.22 µm filter; stored at 4 ºC in cell culture room 
 
Inhibitor stock solution (500 ml) 
10X EBSS (E7510)  50 ml  (final conc. 1X) 
30% D(+)-glucose  6 ml  (final conc. 0.46%) 
1 M NaHCO3   13 ml  (final conc. 26 mM) 
ddH2O    431 ml 
brought to 500 ml with ddH2O and filtered through 0.22 µm filter; kept at 4 ºC in cell culture room 
 
10X low Ovomucoid (200 ml) 
dPBS    150ml 
BSA    3g 
trypsin inhibitor   3g 
pH 7.4; brought to 200 ml with dPBS and filtered; stored aliquots at -20 ºC 
 
10X high Ovomucoid (200 ml) 
dPBS    150ml 
BSA    6g 
trypsin inhibitor   6g 
pH 7.4; brought to 200 ml with dPBS and filtered; stored aliquots at -20 ºC 
 
100X Sato (50 ml) 
Neurobasal 50 ml 
transferrin 500 mg  (final conc. 100 µg/ml) 
BSA  500 mg  (final conc. 100 µg/ml) 
putrescine 80 mg  (final conc. 16 µg/ml) 
progesterone 12.5 µl of 2.5 mg/100 µl EtOH stock  (final conc. 60 ng/ml; 0.2 µM) 
sodium selenite 500 µl of 4 mg+10 µl 1 N NaOH in 10 ml Neurobasal (final conc. 40ng/ml) 
filtered through pre-rinsed 0.22 µm filters; stored aliquots at -20 ºC 
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IP astrocyte base medium (300 ml) 
50% Neurobasal    145.5 ml 
50% DMEM     145.5 ml 
100 U penicillin; 100 µg/ml streptomycin     6    ml P/S stock 
1 mM sodium pyruvate       -     (already included in medium) 
292 µg/ml L-glutamine       -     (already included in medium) 
1X SATO         3    ml 100X stock 
5 µg/ml N-acetyl cysteine    1.5    mg 
 
30% FCS in 50/50 mixture of DMEM and Neurobasal 




IP dishes were prepared by coating six 15 cm Petri dishes with 25 ml 50 mM Tris-HCl (pH 
9.5) per dish and the following secondary antibodies (listed in 3.1.1.3) overnight at 4 C: 
1x secondary only plate: 60 µl anti-mouse IgG+IgM (H+L) 
1x BSL1 plate:  20 µl BSL-1  
1x CD45:   60 µl anti-rat IgG 
2x O4 plate:   60 µl anti-mouse IgM µ-chain specific 
1x ITGB5 plate:  60 µl anti-mouse IgG+IgM (H+L) 
 
The following day, 22 ml enzyme stock solution were added to a 50 ml Falcon tube and 
bubbled with CO2 until the solution turned from red to orange. The enzyme stock solution 
was then kept in the waterbath set to 34 ºC. Similarly, 2 x 21 ml and 1 x 10ml inhibitor stock 
solutions were bubbled but then kept at room temperature. 1.5 ml 10X low Ovo and 100 µl 
0.4% DNase were added to each of the two 21 ml aliquots of bubbled inhibitor stock (low 
Ovo), while 2 ml 10X high Ovo and 20 µl 0.4% DNase were added to the 10 ml aliquot of 
bubbled inhibitor stock solution (high Ovo). Further, 70 ml 0.2% and 40 ml 0.02% BSA were 
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Except for the BSL-1 plate, each panning dish was wished with 1X PBS three times, 
after which 12 ml 0.2% BSA were added together with the following primary antibodies 
(listed in 3.1.1.3) or compounds: 
1x secondary only plate: (only 0.2% BSA) 
1x BSL1 plate:  (leave unwashed and uncoated) 
1x CD45:   20 µl anti-CD45 antibodies 
2x O4 plate:   20 µl anti-O4 antibodies 
1x ITGB5 plate:  20 µl anti-Itgb5 antibodies 
 
Plates were incubated in primary antibody for ≥ 2 hours at room temperature before use. 
 
Dissection 
P7 rat pups were sacrificed by decapitation with scissors, and brains were isolated and further 
dissected in 4 ºC cold 1X dPBS under a light microscope in a semi-sterile dissection hood. 
Meninges and all tissue apart from the cerebral cortex were swiftly removed. 20 minutes 
before the end of dissection, 100 units papain (81.32 µl) and 3.6-4.2 mg L-cysteine were 
mixed in 34 ºC warm enzyme stock solution. Cortices were transferred into small drops of 4 
ºC 1X dPBS and cut into ≈ 1 mm3 pieces with a No. 10 scalpel blade. 
 
Dissociation 
20 ml enzyme solution (including papain and L-cysteine) were filtered through a 0.22 µm 
filter (Millipore, cat. no.: SLGV013SL) and added to the brain pieces alongside 100 µl 0.4% 
DNase. Brain pieces in enzyme solution were bubbled with CO2 for 40 min on a 34 C heat 
block (and shaken every 10 minutes). Next, digested brain pieces were collected in a Falcon 
tube and washed five times with 4.5 ml low Ovo solution. After the last wash, 4 ml low Ovo 
solution were added, and the brain pieces were triturated by pipetting. At the top of the 
suspension, single cells accumulated (vs. small and larger brain pieces sinking to the bottom) 
and were removed using a 1 ml pipette, and added to a separate Falcon tube with 4 ml low 
Ovo solution. In between, trituration steps were repeated (including the addition of 4.5 ml low 
Ovo solution) until the majority of brain pieces were gone. 
 Next, 12 ml high Ovo solution were carefully layered beneath the single cell 
suspension. The Falcon tube with the cell suspension / high Ovo solution biphasic mix was 
then centrifuged at 110 x g for 5 min at 4 ºC to ensure complete inhibition of papain. The 
supernatant was then discarded and the cell pellet was resuspended in 9 ml 4 ºC cold 0.02 % 
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BSA. The solution was then filtered into a 50 ml Falcon tube through an autoclaved 30 µm2 
Nitex mesh to remove remaining chunks of tissue, after which the filter was washed with 3 ml 
4 ºC cold 0.02% BSA. The Falcon tube with the cells was then left in the waterbath at 37 C 
for 30-45 min to allow antigens to return to the cell surface. 
 
Immunopanning 
All following steps were performed at room temperature. Panning dishes were washed with 
1X dPBS three times, after which the cell suspension was passed through a series of 
immunopanning steps: 
1. “secondary only” plate (which had not been incubated with any primary antibodies) 
for 10 min, shaking once at the 5 min time point 
2. BSL-1 plate for 10 min, shaking once at the 5 min time point 
3. CD45 plate for 20 min, shaking once at the 10 min time point 
4. O4 dish #1 for 15 min, shaking once at the 7.5 min time point 
5. O4 dish #2 for 15 min, shaking once at the 7.5 min time point 
6. Itgb5 dish for 40 min, shaking once at the 20 min time point 
 
Subsequently, the Itgb5 dish was washed with dPBS five times. Next, 200 U trypsin were 
added to 8 ml pre-equilibrated 1X EBSS and pipetted onto the Itgb5 dish which was then 
incubated at 37 ºC for 3 min. After this, the side of the dish was tapped to dislodge and 
resuspend cells with 20 ml pre-equilibrated 30% FCS (in 1:1 Neurobasal / DMEM). The cells 
were then added to a fresh Falcon tube, to which 200 µl DNase were added; the Falcon tube 
was then centrifuged at 170 x g at 4 ºC for 11 min. Next, the supernatant was discarded and 
the cell pellet was resuspended in 0.02% BSA. Cells were counted by the Trypan Blue 
exclusion method, and plated at a density of 30,000 cells / well on 12 mm PEI-coated 
coverslips in pre-equilibrated IP astrocyte medium (IPm; 5 ng / ml HBEGF in 1:1 Neurobasal 
/ DMEM). Cultures were maintained in the incubator, and half the medium was exchanged 









Immunocytochemistry was performed according to standard protocols (Whitelam, 1995) with 
minor modifications. 
 
3.2.2.1 Sample preparation 
 
On DIV14, 16, or 21, cell cultures were fixed for 30 min in 4% paraformaldehyde in 0.1 M 
phosphate buffer, after which samples were washed in 1X PBS for 5 x 3 min. Samples were 
then stored in 1X PBS at 4 ºC or immediately used for immunostaining. 
 
3.2.2.2 Immunostaining of cell cultures 
 
Samples were incubated in buffer D (2% donkey serum, 0.1% Triton-X-100, and 0.05% NaN3 
in 2X PBS) for 30 min, and subsequently incubated with primary antibodies (diluted in buffer 
D) at 4 ºC overnight. 
 The following day, samples were washed in 1X PBS for 5 x 3 min, after which 
secondary antibodies (diluted in buffer D) were added and incubated at room temperature in 
the dark for 2 hrs. In some cases, fluorescent staining reagents targeting F-actin (phalloidin 
Atto390 (Sigma, cat. no.: 50556) or phalloidin AlexaFluor647 (Invitrogen, cat. no.: A-
12379)) were added to label the cytoskeleton during the last 30 minutes of incubation with 
secondary antibodies. After secondary antibody incubation, samples were washed in 1X PBS 
for 5 x 3 min. Next, the coverslips were mounted in Fluoromount mounting reagent 
(Diagnostic BioSystems, cat. no.: K048) on glass slides. In some cases, 10 µM DAPI 
(Invitrogen, cat. no.: D1306) was added to the mounting reagent. After mounting, the edges of 
coverslips were sealed with transparent nail polish. Samples were stored at 4 ºC in the dark. 
 
3.2.2.3 Fluorescein In Situ Apoptosis Detection 
 
For the apoptosis test comparing IP and NB+H astrocytes grown in HBEGF-containing with 
HBEGF-free media, the ApopTag® Fluorescein In Situ Apoptosis Detection Kit (Millipore, 
cat. no.: S7110) was used according to the manufacturer’s recommendations.  
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3.2.3 Histological analysis 
 
3.2.3.1 Transcardial mouse perfusion 
 
Several preparations were made in advance: 4% paraformaldehyde and 1X PBS were kept on 
ice and hypodermic needles (Sterican / B. Braun) were set aside for pinning down mice. The 
pumping speed of the Masterflex C/L PWR pump (Cole Palmer) was tested and adjusted 
using water. The butterfly venipuncture set (B. Braun, cat. no.: 4056388) was set up with its 
tubing in a dH2O-filled beaker, while the tubing of the butterfly needle was placed into a 
Falcon tube containing 1X PBS on ice. 
Adult C57B/6J mice were anaesthetised by CO2. After testing if mice were fully 
unconscious (e.g. by pinching the paw), they were swiftly pinned down on a styropor block. 
The chest and abdomen were sprayed with ethanol and opened with scissors just beneath the 
skin. Next, the ribcage was opened and the butterfly needle was inserted into the left ventricle 
of the heart, while a small incision was made on the right atrium, causing PBS to rinse the 
bloodstream. After all blood was rinsed out, the tubing connected to the butterfly needle was 
moved from the Falcon tube containing PBS and placed in the paraformaldehyde-containing 
Falcon tube on ice, so that the mouse tissue was fixed as paraformaldehyde was pumped 
through the blood vessels. 
 Once mice were fully perfused with paraformaldehyde, the pump was stopped to 
allow for tissue dissection. 
 
3.2.3.2 Sample preparation 
 
Immediately after transcardial perfusion, mouse heads were cut off using scissors, sprayed 
with ethanol, and the brains were removed and transferred to 4% paraformaldehyde in fresh 
Falcon tubes for overnight storage. 
 The following day, brains were washed in 1X PBS 2 x 2 hrs, after which brains were 
moved to Falcon tubes containing 30% sucrose solution and kept at room temperature 
overnight. By the next day, brains had sunk down to the bottom of the tube, at which point 
they were frozen in cryomolds containing Tissue Tek O.C.T. compound on dry ice. Frozen 
brains were then loaded onto the Leica CM1850UV cryostat to cut cryosections, which were 
collected in ethylene glycol and stored at 4 ºC overnight. 
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3.2.3.3 Immunostaining of cryosections 
 
Cryosections were washed with 1X PBS for 3 x 20 min; all washing steps were performed on 
a horizontal shaker. Cryosections were then incubated in buffer D for 2 hrs at room 
temperature. Next, the samples were incubated in primary antibodies for 24 hrs at 4 ºC on a 
horizontal shaker, after which samples were washed for 3 x 20 min with 1X PBS. Following 
this, secondary antibodies were applied at 4 ºC overnight, and afterwards, samples were 
washed with 1X PBS for 3 x 20 min. After the last washing step, 1 ml 1X PBS was pipetted 
onto a glass slide, into which a single cryosection was placed using a brush. Excess PBS was 
removed using a 100 µl pipette and kimwipes, after which 10 µl Fluoromount mounting 
reagent was added onto the cryosection. A 25 mm coverslip was carefully placed on top of the 
sample, and after the mounting reagent had dried, the coverslips were sealed with nail polish. 
 
 





Immunoblotting was performed according to standard protocols (LaRochelle, 2009), with 
minor modifications. 
 
3.2.4.1 Sample preparation of cell cultures 
 
DIV9, 14, and 21 cultures were washed with 1X PBS, which was then replaced by 500 µl 
fresh 1X PBS. Using a cell scraper (CytoOne, cat. no.: CC76000220), cells were detached 
from the culture dish, and this cell suspension was transferred into an eppendorf tube. The cell 
suspension was then triturated five times using a 27 gauge needle (HSW Fine-ject, cat. no.: 
4710004020), after which samples were centrifuged at 400 x g in an eppendorf centrifuge 
5424 for 10 min at 4 ºC. Next, the supernatant was moved to a fresh tube, which was 
centrifuged as before. After transferring the supernatant to a fresh tube, protein concentration 
was determined using the BCA protein assay kit (Novagen, cat. no.: 712853) according to the 
manufacturer’s recommendations. 
 
3.2.4.2 Sample preparation of brain lysate 
 
Brain lysate was prepared as a positive control for proteins expressed in vivo. Adult C57B/6J 
mice were euthanised by cervical dislocation. Brains were isolated and transferred to a Petri 
dish with 4 ºC homogenisation buffer (320 mM sucrose, 4 mM Hepes-KOH, pH 7.4) on ice. 
Next, brains were dissected further and then placed in 1.5 ml eppendorf tubes containing 500 
µl homogenisation buffer on ice. Brains were then homogenised using a homogenator rod set 
to 900 rpm in a laboratory stirrer (VWR VOS 14 S40) in a 4 ºC cold room. After this, tubes 
with homogenised brain lysate were centrifuged at 1,000 x g for 10 min at 4 ºC. Supernatant 
was aliquoted and snap-frozen in liquid nitrogen for storage at -80 ºC. 
 
3.2.4.3 Gel electrophoresis 
 
The outer gel running chamber was filled with anode buffer (1 M Tris in dH2O, adjusted to 
pH 8.9), and cathode buffer (1 M Tris, 1 M Tricin, 1% SDS in dH2O) was added to the inner 
cassette, into which 1.5 mm thick 10% acrylamide running gels (including 5% stacking gels) 
were placed. After this, 5 µg of each sample were loaded alongside a molecular weight 
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marker (PageRulerTM prestained protein ladder by Fermentas, cat. no.: SM0671). Gel 
electrophoresis was started at 60 V, and after 15 min, switched to 100 V for another hour. 
 
3.2.4.4 Immunoblot transfer 
 
After gel electrophoresis, the running gel with the samples was equilibrated in blotting buffer 
(200 mM glycine, 25 mM Tris, 0.04% SDS, 20% methanol) for 10 min. Fibre pads, 
nitrocellulose membranes, and filter papers were also equilibrated in blotting buffer. The 
blotting sandwich in the blot transfer apparatus, was stacked as follows (cathode to anode 
end): one fibre pad, one filter paper, the gel, one nitrocellulose membrane, one filter paper, 
one fibre pad. The transfer was started at 100 mA, and run for 1 h. 
 
3.2.4.5 Protein detection 
 
Following the transfer, membranes were blocked in 5% milk in PBS-T (0.05% Tween 20 in 
1X PBS) for 1 h, and then incubated in primary antibodies in 5% milk in PBS-T at 4 ºC 
overnight. The next day, membranes were washed in 1X PBS for 5 x 5 min, and then 
incubated in secondary antibodies in 5% milk in PBS-T at 4 ºC overnight. Subsequently, each 
membrane was washed in 1X PBS for 5 x 5 min, followed by applying ECL solution (1.28% 
(w/v) Tris-HCl and 0.23% (w/v) luminol Na+ salt (Sigma, cat. no.: A4685-1g) in dH2O (pH 
8.6), 0.01% P-coumaric acid (Sigma, cat. no.: 9008-5g) in DMSO, 0.008% H2O2) to the 
membrane for 1 min. Protein detection was achieved using the Fujifilm LAS-3000 imaging 
system (R&D Systems). Membranes intended for re-probing were washed in 1X PBS for 10 
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3.2.5 Electron microscopy 
 
Sample preparation was done with assistance from Torben Ruhwedel (MPI for Experimental 
Medicine, Göttingen, Germany), and images were acquired by Dr. Wiebke Möbius (MPI for 
Experimental Medicine, Göttingen, Germany). 
 
3.2.5.1 Sample preparation 
 
Epon embedding 
Briefly, 2-week-old cell cultures (co-cultures, MD, IP, and NB+H astrocyte monocultures) 
were fixed in 1% paraformaldehyde solution for 1 h. Samples were subsequently washed in 
1X PBS and then embedded in Epon (Epon embedding steps included osmification, 
dehydration, and Epon impregnation). 
 
Cutting sections of Epon embedded cultures 
Epon embedded cultures were cut on a microtome (Ultracut S, Leica, Germany). Using a 
diamond knife (Diatome Ultra 45 º), ultra-thin (50 nm) sections were cut and collected on 
double-sized slot grids (2mm-1mm, AGAR Scientific, UK). Samples were then coated with 
formvar polyvinyl, and contrasted. 
 
Contrasting ultra-thin sections 
Grids with samples were placed upside-down on drops of the following series of solutions: 
1. uranyl acetate (covered from light sources) for 30 min 
2. ddH2O for 1 min 
3. Reynolds lead citrate for 6 min 
4. ddH2O for 4x 1 min 
The grids were then dried with filter paper and stored at room temperature until imaging. 
 
Imaging 
Samples were imaged by Dr. Wiebke Möbius, using the Zeiss EM900 (Zeiss, Germany) and a 
wide-angle dual speed 2K CCD camera (TRS, Germany).  
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3.2.6 Transfection and antibody internalisation assays 
 
The following plasmid DNA was used for the antibody internalisation assays: pHluorin-
Vamp2, pHluorin-Syt7, and pHluorin-Syt17; all constructs contained an ampicillin- resistance 
gene. The plasmid DNA listed here had previously been tested by overexpression of 
pHluorin-coupled Syts in HEK cells and subsequent immunostaining, where antibodies 
recognised overexpressed Syts (Camin Dean, unpublished). 
 For tetanus toxin (TeNT) experiments, purified TeNT light chain peptides were a gift 
from Dr. Yongsoo Park and Prof. Reinhard Jahn (Max Planck Institute for Biophysical 
Chemistry, Göttingen, Germany) TeNT peptides were introduced to cells by transfection, 
which had previously been successful (Kuo et al., 2010). 
 
3.2.6.1 Plasmid DNA amplification 
 
E. coli strain XL-1 Blue cells (Stratagene, cat. no.: 200249) were thawed on ice. 100 µl of the 
cells were mixed with 100-500 ng plasmid DNA in a fresh tube and incubated on ice for 15 
min. Bacteria were heat-shocked at 42 ºC for 1 min, and immediately placed back on ice for 2 
min. Next, 900 µl LB medium (Roth, cat. no.: X968.1 ; prepared according to the 
manufacturer’s recommendations) were added, and then shaken at 800 rpm using an 
eppendorf thermomixer (for 1.5 ml tubes) at 37 ºC for 1 h. Using an ethanol-sprayed, bent 
glass pipette, 200 µl of the bacterial mix was spread over a 10 cm LB-agar plate (that 
contained 0.5% yeast extract, 1% tryptone (pH 7), 1% NaCl, and 1.5% agar in LB medium), 
together with 100 µg/ml ampicillin (Roth, cat. no.: K029.2) or 50 µg/ml kanamycin (Roth, 
cat. no.: T832.3). Plates were then incubated at 37 ºC overnight. 
 The next day, single isolated bacterial colonies were selected and each was added to 
an Erlenmeyer flask containing 100 ml pre-warmed LB medium with 50 µg/ml of the 
respective antibiotic. Flasks were incubated at 300 rpm and 37 ºC for 16-24 hrs. After that, 
bacterial suspensions were centrifuged at 3,220 x g and 20 ºC for 15 min. Supernatants were 
discarded and pellets were resuspended in 1X PBS. This suspension was centrifuged once 
more, and the supernatant was discarded. The resulting plasmid DNA was purified using the 
Qiagen Plasmid Maxi kit (Qiagen, cat. no.: 12162) according to the manufacturer’s 
recommendations. DNA concentration was measured using a NanoPhotometer Implen 
(Montreal Biotech Inc.). 
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3.2.6.2 Transfecting cultures 
 
Cell cultures were transfected in 24-well plates, in serum-free media pre-heated to 37 ºC. For 
each coverslip, 1 µl LipofectamineTM 2000 transfection reagent (Invitrogen, cat. no.: 
11668027) was added to 50 µl medium in an eppendorf tube and in a separate tube, 0.7 µg 
plasmid DNA was added to 50 µl medium. Both mixes were incubated at room temperature 
for 5 min before mixing them. The mix of lipofectamine reagent and DNA was then incubated 
for 30 min. 
For co-cultures, medium was removed and saved, and 400 µl of fresh pre-heated 
Neurobasal medium was added to each well of the co-cultures. For astrocyte monocultures, 
medium was discarded, and 400 µl of fresh pre-heated DMEM (without serum) was added per 
well to the astrocytes. Next, 100 µl of the lipofectamine / DNA mix was added to each well 
and incubated at 37 ºC and 5% CO2 for 2.5 hrs. Afterwards, medium was removed, and cells 
were washed once in fresh pre-heated medium. Finally, the saved medium was added back to 
co-cultures, while astrocyte monocultures received fresh pre-heated medium. 
Transfected cells were used for the antibody internalisation assay 2 days after 
transfection. 
 
3.2.6.3 Antibody internalisation assays 
 
Coverslips with cell cultures that had been transfected two days earlier were moved into new 
24-well plate wells, in which anti-GFP antibodies (diluted 1:500) were mixed into pre-heated 
stimulating solution (50 µM glutamate, 10 mM KCl, 135 mM NaCl, 2 mM CaCl2, 5.5 mM 
glucose, 2 mM MgCl2, and 20 mM HEPES) or non-stimulating solution (2 mM KCl, 143 mM 
NaCl, 2 mM CaCl2, 5.5 mM glucose, 2 mM MgCl2, and 20 mM HEPES). Cells were kept in 
the incubator for 10 min, after which they were moved to new wells containing 4% 
paraformaldehyde for fixation for 30 min. After this step, samples were treated as described in 
3.2.2.2. 
 





3.2.7 Adeno-associated viruses for Ca2+ imaging 
 
The vector plasmid pZac2.1 gfaABC1D-Lck-GCaMP3 was a gift from Baljit Khakh 
(Addgene plasmid # 44330). Adeno-associated viral (AAV) particles of the 1/2 serotype 
carrying the vector plasmid were provided by Markus Stahlberg (European Neuroscience 
Institute, Göttingen, Germany). 
 
3.2.7.1 Viral infection 
 
Prior to infection, half the medium of cultures was exchange with fresh pre-heated medium. 
Cultures were subsequently infected with 0.3 µl AAV particles / well of a 24-well plate, after 
which the next half medium exchange was performed 7 days later. Infected cultures were 
used for live cell Ca2+ imaging 10 days after infection. 
 In contrast to co-cultures and MD and NB+H monocultures, the AAV infection caused 
IP astrocyte cell health to deteriorate in 50% of the cases, so that several repetitions were 
necessary. 
 




Coverslips with infected cell cultures were placed in a low profile open bath chamber (Warner 
Instruments, cat. no.: RC-40LP), and immediately placed on the Zeiss LSM710 confocal 
microscope for imaging, prior to which the imaging chamber had been filled with pre-heated 
non-stimulating solution (2 mM KCl, 143 mM NaCl, 2 mM CaCl2, 5.5 mM glucose, 2 mM 
MgCl2, and 20 mM HEPES). Spontaneous Ca
2+ signalling (as indicated by GCaMP3 signal) 
was monitored for 200 seconds, and cells were only used during a 30-minute period (some 










Fixed samples (of immunocyto- and immunohistochemistry) but also GCaMP3-infected, live 
cell cultures were imaged using the Zeiss LSM 710 confocal microscope (Zeiss, Germany), 
equipped with 405, 488, 561, and 633 nm lasers. Images were obtained using Zen Black 
software.  Within the same experiment, image acquisition, settings for light intensity, electron 
multiplication (EM gain), and exposure time were kept the same. 
 
The following objectives were used for fixed samples: 
20X / 0.8 objective (Zeiss, Plan-Apochromat) 
40X / 1.3 oil DIC objective (Zeiss, Plan-Apochromat) 
63X / 1.4 oil DIC objective (Zeiss, Plan-Apochromat) 
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3.2.9 Data analysis 
 
3.2.9.1 Data analysis of immunostainings and immunoblots 
 
Microsoft Excel 2010 software was used for creating bar graphs and statistical tests (for 
calculating standard error of the mean, p values, Student’s t-test). Figures of immunostaining 
and immunoblotting experiments were prepared via Adobe Photoshop CS5.1 software. Bar 
graphs, diagrams, and figure assembly was finalised in Adobe Illustrator CS5.1 software. 
Synapse numbers were counted by automated macros written for ImageJ / Fiji 
software. Co-localisation of Vamp2 / Syt immunostainings was analysed using MetaMorph® 
Microscopy Automation & Image Analysis software. 
 




To analyse Ca2+ events from movies of live cell Ca2+ imaging using GCaMP3 signal 
expressed exclusively in astrocytes, the ImageJ / Fiji plugin GECIquant was used (Srinivasan 
et al., 2015), which is a tool for semi-automatic detection and quantification of genetically 
encoded Ca2+ signals. 
GECIquant was used to define soma, branchlet and microdomain regions within 
which Ca2+ fluctuations were quantified. A Matlab code was written and used to further 
define, quantify, and display events as described below. For every condition / event-type, all 
ROIs with greater than 10% total frames of 0 fluorescence (in at least two consecutive 
frames) were excluded from analysis. Ca2+ events within each region were detected from the 
absolute fluorescence values output by GECIquant, and plotted as dF/F. 
For somatic events in MD and IP astrocytes (which were slow-rising and infrequent), 
the baseline fluorescence was calculated as the average of 15 frames before and 15 frames 
after the minimum fluorescence value (i.e. average of 30 frames total). An event was then 
defined as having at lest 30 frames above 3.5 x RMS  (root mean square) noise. The event 
amplitude was calculated as the average of 30 frames around the maximum value. For 
somatic events in co-culture and NB+H astrocytes, the average of the 75th percentile (average 
of 75% of the total frames with the lowest fluorescence values) was used to calculate the 
baseline; an event was defined as fluorescence values above a threshold of 3.5 x RMS noise, 
where single points above the threshold, or the maximum value of a cluster of points above 
the threshold were used to define amplitude and half-width. 
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Branchlet events were defined as for the soma in each condition. Except in co-culture 
and NB+H conditions, events were defined as being above the 91.5 th percentile of all events 
(to exclude small “events” that looked like noise upon visual inspection). 
The baseline for microdomain events was defined as the mean of all fluorescence 
values in each trace. (Because microdomain events were shorter-lived and lower in amplitude 
than somatic and branchlet events, the average of all fluorescence values best approximated 
baseline). Microdomain events were then defined as above for branchlet events. Peak half-
width was defined as the duration of peak width at half maximal amplitude. 
 





4.1 Characterisation of different astrocyte cultures 
 
4.1.1 Specific media alter astrocyte morphology, protein expression, and 
proliferation 
 
To study vesicle characteristics of astrocytes in culture, we first tested different culturing 
methods: co-cultures (of neurones, astrocytes, and other glia) and astrocyte monocultures 
generated by the MD and IP methods (see Table 1). 
Co-cultures are best generated from embryonic day 18-19 tissue, whereas MD 
astrocyte monocultures are usually derived from P0 to P3 tissue when astrogliogenesis peaks 
in the central nervous system (Freeman, 2010). In the spinal cord, astroglial precursors start to 
express glial fibrillary acidic protein (Gfap) and excitatory amino acid transporter 1 (EEAT1, 
also known as GLAST or SLC1A3) on embryonic day 14 (Deneen et al., 2006; Fan et al., 
2005), whereas astrogliogenesis begins later in the prenatal cortex (He et al. 2005; Miller and 
Gauthier 2007; Ge et al. 2012). To obtain relatively mature astrocytes for monocultures but 
also prepare co-cultures from the same animals for comparison, we chose to dissect tissue 
from embryonic day 19 animals (i.e. shortly before birth) for co-cultures and MD astrocytes 
prepared from cortex. In contrast, we prepared IP astrocytes from one week-old rats as 
suggested by the authors of the IP method (Foo, 2013b; Foo et al., 2011).  
As described in Table 1, astrocyte morphology and protein expression depend on the 
cell culture method. When we compared astrocytes from co-cultures (of neurones and glia) 
with MD and IP astrocytes, the morphology varied: While co-culture and IP astrocytes 
appeared stellate, similar to astrocytes in vivo, MD astrocytes were polygonal (Fig. 8). Apart 
from the protocols used, another difference between these cultures is the medium (co-cultures 
are grown in Neurobasal medium with B-27 and glutamax supplements (NB+), MD 
astrocytes are grown in DMEM including 10% FCS, (DMEM+) and IP astrocytes are grown 
in a mix of NB+ and DMEM including human epidermal EGF-like growth factor (HBEGF). 
Interestingly, the culture medium determines how embryonic stem cells proliferate and 
differentiate (Draper et al., 2004), and fibroblast cultures (with a morphology similar to MD 
astrocytes) can be directly trans-differentiated into epiblast stem cells via transcription factors 
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only in epiblast stem cell medium (Han et al., 2011). Therefore, we tested whether using 
different media would make MD astrocytes more similar to co-culture astrocytes by 
morphology (Fig. 8). 
 







Fig. 8: Conditioned medium from co-cultures makes astrocytes more similar to co-
culture and IP astrocytes by morphology 
Immunocytochemistry of DIV14 co-cultures (neurones with glia) and DIV16 astrocyte monocultures: 
MD astrocytes grown in DMEM+, IP astrocytes, and MD astrocytes treated with Neurobasal medium 
including supplements (NB+) –like co-cultures– or with conditioned medium from co-cultures (NB++), 
are shown. Gfap labels astrocytes, βIII tubulin labels neurones, and DAPI labels cell nuclei. 
Secondary antibody controls are provided in Fig. 9. Similar morphology was observed in n=7 (co-
cultures, IP, NB++) and n=3 (MD, NB+) culture preparations. Scalebar = 50 µm. 
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Growing MD astrocytes in NB+ changed astrocyte morphology from polygonal to 
bipolar and often stellate. However, cell survival was low, so these astrocytes were plated at a 
higher density than MD astrocytes grown in DMEM+, for comparison of different culture 
methods  (discussed later in this chapter, see Fig. 11). In contrast to MD astrocytes grown in 
NB+, astrocytes in co-cultures are also exposed to neuronal secreted factors that may 
influence astrocyte morphology, protein expression, and proliferation. Indeed, when 
conditioned medium from day in vitro (DIV) 7 co-cultures (NB++) was transferred to DIV7 
MD astrocytes, their morphology became bipolar to stellate as in the NB+-treated MD 
astrocytes. In addition, cell survival of conditioned medium-treated astrocytes was similar to 
that of MD and IP astrocytes (data not shown). Thus, adding conditioned NB++ to MD 
astrocytes on DIV7 proved an easier and faster protocol than generating IP astrocytes, while 
providing more stellate astrocyte morphology than the traditional MD astrocyte protocol. 
 
 





While this quick and simple method saved time and effort, an extra set of co-cultures had to 
be prepared for each set of MD astrocyte monocultures to be used to generate NB++ medium, 
and potential batch variation was an issue. Thus, we decided to test which medium 
composition causes the most “in vivo-like” astrocyte morphology, with a goal to develop 
chemically defined media rather than preparing extra co-cultures that produce media with 
unknown constituents. 
 
Fig. 9: Secondary antibody controls for immunocytochemistry 
Control immunocytochemistry with secondary antibodies (2º a.b. ) and DAPI or Gfap primary antibody. 
A DIV14 co-cultures (top panel) and DIV16 MD astrocytes (bottom panel) treated with the indicated 
combinations of 2º a.b. and DAPI. 2º a.b. against rabbit (rb), guinea pig (gp), and mouse (m) were 
used. B DIV16 MD astrocytes treated with a primary a.b. against Gfap and then a donkey anti -goat 2º 
a.b. followed by a goat anti-rb 2º a.b. applied individually and consecutively to avoid donkey anti-goat 
2º a.b. binding to goat anti-rb 2º a.b. (as a control for later figures, i.e. Fig. 23B), n=5 (A), and n=4 (B) 
individual immunostains yielded similar results. Scalebar = 10 µm. 
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We found that astrocytes develop a stellate morphology when grown in Neurobasal 
medium with HBEGF (NB+H), regardless of whether they were prepared by the MD or IP 
method (Fig. 10A). NB+H mixed with DMEM (i.e. IPm – the medium used for IP astrocyte 
cultures by Foo et al.) also yielded stellate astrocytes, but with slightly fewer thin processes. 
However, growing astrocytes in DMEM+ alone (with or without HBEGF) made astrocytes 
polygonal, even when the cells were generated by immunopanning. Therefore, HBEGF 
supported stellate morphology in MD astrocytes, but only when combined with Neurobasal 
medium. As a result, we selected this simple and fast protocol for further analysing astrocytes 
in culture (i.e. incorporating the MD method of shaking astrocytes on DIV7, but then growing 
them in NB+H); monocultures generated in this way will be referred to as NB+H astrocytes 
from here onwards. 
Next, we compared MD, IP, and NB+H astrocytes with co-cultures and whole brain 
lysate by Western blot analysis (Fig. 10C). Notably, the cell yield of IP astrocytes was much 
lower than for other cultures, so that loading enough IP astrocyte lysate onto Western blot 
gels for multiple antibody analysis was challenging, demonstrating a disadvantage of this 
protocol over MD and NB+H astrocytes. 
  




Fig. 10: Different media yield morphologically different astrocytes 
A Immunocytochemistry of DIV14 co-cultures and the indicated types of DIV16 astrocyte 
monocultures. Aldh1L1 and Gfap label astrocytes and Map2 labels neuronal processes. MD and IP  
astrocyte preparations were grown in different media as explained in B: Co-cultures were directly 
plated in NB+, whereas MD astrocyte monocultures were shaken on DIV7 and then grown in either 
DMEM with 10% fetal calf serum (DMEM+) for classical MD astrocytes, NB+ with heparin -binding 
EGF-like growth factor (HBEGF) (NB+H), DMEM+ with HBEGF (DMEM+H), or the medium used in 
the Foo et al. IP astrocyte protocol (IPm), which is a 1:1 mix of DMEM and NB+H. IP astrocytes were 
generated as described by Foo  et al. (2013) and grown in IPm, NB+H, or DMEM+. In A and B, the 
blue square marks MD cultures grown in NB+H (NB+H astrocytes), which we selected for further 
analysis due to the stellate morphology and ease of production. C Western blot analysis of adult rat 
brain lysate compared with DIV14 co-culture, MD, IP, or NB+H astrocyte lysate. Different antibodies 
against proteins that mark astrocytes (Aldh1L1, Gfap), immature or reactive astrocytes (Vimentin, 
Gfap), mature astrocytes (S100β), neurones (synaptophysin (Syp)), oligodendrocytes (myelin basic 
protein (Mbp)), and microglia (Cd11b) were used; Gapdh serves as a loading control. Western blots 
were prepared by Dr. Saheeb Ahmed (European Neuroscience Institute, Göttingen). From top to 
bottom, immunostains yielded similar results in n=6, 4, 8, 4, 8, 5, 4, 6 for each panel in A. Scalebar = 
10 µm. 
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 All samples included astrocytic proteins, e.g. aldehyde dehydrogenase 1 family 
member L1 (Aldh1L1) and glial fibrillary acidic protein (Gfap). Similarly, all samples 
expressed Vimentin and Nestin, which are markers of immature and reactive astroc ytes (Dahl 
et al., 1981; Pixley and de Vellis, 1984; Schiffer et al., 1986). We found the highest Vimentin 
levels in MD astrocytes, and the lowest in IP astrocytes, indicating that IP astrocytes are more 
mature than MD astrocytes. While Nestin expression was similar in all samples, S100β 
expression was opposite to Vimentin expression (highest in IP astrocytes and lowest in MD 
astrocytes); S100β is expressed by mature astrocytes that have lost their stem cell potential 
(Raponi et al., 2007), again indicating that IP astrocytes are more mature than MD astrocytes. 
 Proteins characteristic of other, non-astrocytic cell types were only found in brain 
lysate and co-cultures, i.e. synaptophysin (marking neurones), myelin basic protein (marking 
oligodendrocytes), and Cd11b (marking microglia). Thus, MD, IP, and NB+H monocultures 
were free of any other cell types than astrocytes. 
 Both IP and NB+H astrocytes were stellate and expressed low Vimentin levels 
compared with MD astrocytes. Foo et al. (2011) reported that HBEGF is essential for IP 
astrocyte survival. However, in Fig. 8 we show that astrocytes grown in NB+ without HBEGF 
do survive (although astrocytes need to be plated at a higher density to survive). To test 
whether IP astrocytes undergo apoptosis without HBEGF, or whether plating IP astrocytes at 
a higher density can rescue cell survival as in NB+H astrocytes grown without HBEGF (see 
Fig. 8), we compared IP and NB+H astrocytes grown with or without HBEGF. 
 After growing IP and NB+H astrocytes with or without HBEGF for 14 days, we 
labelled apoptotic cells using the Apoptag® Fluorescein kit, and used DAPI to detect all cell 
nuclei (Fig. 11A). IP astrocytes plated at both low and high densities survived in HBEGF-free 
media. Although this growth factor was not required for IP astrocyte survival, the cell number 
after 14 days was significantly higher in IP astrocytes grown in HBEGF-containing medium 
(Fig. 11B). The same was true for NB+H astrocytes, which showed a dramatic decrease in 
cell number in the absence of HBEGF. However, assessing the relative proportion of 
apoptotic cells revealed that more than half of all cells counted by DAPI staining were alive in 
any HBEGF-free condition (Fig. 11C). Although both NB+H and IP astrocytes survived 
without HBEGF, HBEGF contributed significantly to cell proliferation. Therefore, we 
included HBEGF in IP and NB+H astrocyte media for further experiments. 






Another difference between IP and NB+H astrocytes is the tissue age the cells are 
generated from. One advantage of the IP protocol is that it allows isolating astrocytes from 
older animals (up to postnatal day (P) 14 according to (Foo et al., 2011). Thus, we tested if IP 
astrocytes derived from younger tissue like NB+H astrocytes (P0) change by morphology, 
and conversely, if NB+H astrocytes derived from older tissue (P7, as Foo et al. recommend 
for IP astrocytes) change by morphology.  
 
Fig. 11: HBEGF promotes astrocyte proliferation 
A Immunocytochemistry of DIV14 IP and NB+H astrocytes plated at 10,000 or 40,000 and 5,000 cells 
/ 24-well coverslip, respectively. Fluorescein marks apoptotic cells and DAPI marks all cell nuclei. For 
each condition, cell number in media with or without HBEGF was compared and quantified in B as 
absolute numbers and in C as relative numbers. n=12 for images from 4 cultures. Error bars: SEM, **= 
p < 0.01, ***= p < 0.001, n.s.= p > 0.05 by an unpaired two-tailed Student’s t-test. Scalebar = 100 µm. 




Fig. 12: Older tissue yields fewer but viable astrocytes 
A Immunocytochemistry of DIV14 IP astrocytes derived from P0, P4, or P8 rats, where Aldh1L1 and 
Gfap depict astrocyte morphology. B Immunocytochemistry of DIV14 NB+H astrocytes derived from 
P0 or P7 rats, and dissociated with trypsin, papain, or as described in Foo et al. (2013) but without 
immunopanning before plating cells. As in A, Aldh1L1 and Gfap depict astrocyte morphology. C 
Quantification of cells counted per image in the indicated conditions. Images per experiment: n=12 
(P0) and 11 (P4 and P8) in A, and n=6 (P0), n=8 (P7, trypsin), n=6 (P7, papain), and n=16 (IP-like) in 
B. Error bars: SEM, **= p < 0.01, ***= p < 0.001 by unpaired two-tailed Student’s t test. Scalebar =    
25 µm A and 50 µm B. 
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Fig. 12A shows that IP astrocyte morphology was stellate no matter if cells were 
derived from P0, P4, or P8 tissue. However, P8-derived IP astrocytes showed the most refined 
processes. In the IP protocol, tissue is digested with papain, while tissue for generating NB+H 
astrocytes from perinatal tissue is digested with trypsin, which may be more harsh to cells 
(Kaiser et al., 2013). Astrocytes in older tissue have more refined, intermingled processes, so 
that using papain may be important for maintaining cell health when digesting older tissue. 
Consequently, we tested protocols in which we digested P7 tissue for NB+H astrocyte 
monocultures with trypsin, but also tested papain, and the entire IP protocol (minus the 
immunopanning steps) (IP-like). As IP astrocytes, NB+H astrocytes could be generated from 
older tissue (P7), but NB+H astrocyte morphology was equally stellate amongst P0- and P7-
derived cultures (Fig. 12B). Subsequently, we compared NB+H astrocyte numbers following 
trypsin, papain, or IP- like tissue preparations (Fig. 12C). We achieved the greatest cell yield 
from P0-derived astrocytes, but among older NB+H astrocytes, cell numbers were highest 
when using papain. In conclusion, both IP and NB+H astrocytes can be generated from 
perinatal and older postnatal tissue, where tissue digestion with papain yields the most cells. 
Results – 4.1.2 Ca
2+
 signalling profiles in different astrocyte cultures  
 
 75 
4.1.2 Ca2+ signalling profiles in different astrocyte cultures 
 
Unlike neurones, astrocytes are electrically silent, but they employ another inter- and 
intracellular signalling method: Ca2+ signalling (Khakh and McCarthy, 2015; Scemes and 
Giaume, 2006). To compare Ca2+ signalling parameters of the different astrocyte cultures, we 
transduced astrocytes of co-cultures and monocultures with adeno-associated viral particles 
carrying GCaMP3 (a genetically encoded Ca2+ indicator). By using the astrocyte-specific 
Gfap promoter, we ruled out that neurones expressed GCaMP3 in co-cultures. Further, 
GCaMP3 was fused to the membrane-tethering Lck domain. Lck-GCaMP3 reports Ca2+ 
events even in fine astrocyte processes, and is thereby superior to conventional GCaMPs 
without the membrane-tethering domain (Shigetomi et al., 2010b). 
 Using semi-automated GECIquant analysis (Srinivasan et al., 2015), Ca2+ signals were 
first categorised by defining three domains in infected astrocytes: somata (area ≥ 30 µm2), 
branchlets (after subtracting somata: area of 5 - 2000 µm2), and microdomains (area of        
0.5 - 4 µm2). Subsequently, we compared fluorescence intensity of Ca2+ events occurring in 
these three domains from all cultures. Example traces illustrate that astrocytes from co-
cultures and NB+H cultures showed Ca2+ events distinct from MD and IP astrocytes (Fig. 
1A): While clearly distinguishable Ca2+ events appeared in traces from co-cultured and NB+H 
astrocytes, MD and IP astrocytes exhibited mostly wave- like fluorescence intensity changes 
which often persisted even after the end of the experiment (e.g. Fig. 1A, MD astrocytes, 
second somatic trace from the top). In addition, viral transduction was only successful half the 
time for IP astrocytes, which were also prone to apoptosis. 
 To compare Ca2+ signalling parameters in more detail, we analysed event frequency, 
amplitude, and duration for all cultures (Fig. 1B). Event frequency in somata was similar 
between co-culture and NB+H astrocytes, and between MD to IP astrocytes. In addition, the 
frequency of branchlet events was also similar in co-cultures and NB+H astrocytes, and much 
higher than in MD and IP astrocytes types. Thus, Ca2+ event frequency was much higher in 
both somata and branchlets of co-cultures and NB+H compared with MD and IP astrocytes. 
In microdomains, Ca2+ event frequency was the same across all cultures (although IP 
astrocytes showed a trend toward a decrease in frequency, with high error, given that many IP 
astrocytes did not survive transduction).  
 Concerning Ca2+ event amplitude, microdomains of co-cultures showed significantly 
lower amplitude than microdomains in astrocyte monocultures. In contrast, Ca2+ event 
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amplitude was the same in somata and branchlets of all culture types (except for amplitude in 
MD branchlets, which was significantly higher than in co-cultures and NB+H astrocytes). 
 In terms of Ca2+ event duration (plotted as event half-width), we found no difference 
in any domains between MD and IP astrocytes. In somata and branchlets, event duration was 
significantly longer in MD and IP astrocytes than in co-culture and NB+H astrocytes, but in 
microdomains, event duration was significantly shorter in MD and IP astrocytes than in co-
culture and NB+H astrocytes. Co-culture or NB+H event duration in general were similar to 
each other, but differed from all other cultures. 
 We next compared astrocytic Ca2+ signalling in somata, branchlets, and microdomains 
from within one culture type (Fig. 13C). In each culture type, the amplitude of Ca2+ events in 
microdomains was significantly higher than in branchlets or somata. Similarly, microdomain 
Ca2+ event duration was significantly shorter than branchlet and soma Ca2+ event duration. In 
co-cultures, soma and branchlet Ca2+ event amplitude and duration differed, but in astrocyte 
monocultures, soma and branchlet Ca2+ event amplitude and duration was the same. Thus, 
only co-cultures displayed distinct Ca2+ event amplitude and duration properties between all 
three domains (soma, branchlets, microdomains). 
Ca2+ event frequency was comparable between the three domains of all astrocytes. 
Apart from frequency, astrocytes of all cultures had two things in common: (1) the Ca2+ event 
amplitude was significantly higher in microdomains than branchlets or somata, and (2) the 
Ca2+ event duration was significantly shorter in microdomains than branchlets or somata. 
Thus, microdomains shared similar characteristics in all culture conditions, i.e. short, high-
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In summary, Ca2+ events occurred in astrocytes of all culture types as identified by 
GCaMP3 signal. Co-culture and NB+H astrocyte Ca2+ signalling was distinct from MD and 
IP astrocyte Ca2+ signalling: (a) MD and IP astrocyte somata and branchlets had lower Ca2+ 
event frequency and longer event durations than co-culture and NB+H astrocytes (which had 
similar event frequencies); (b) MD and IP astrocytes showed the longest Ca2+ events in 
somata and branchlets, but the shortest Ca2+ events in microdomains (the opposite was true 
 
 




 signalling in DIV16 co-cultures, and MD, IP, and NB+H astrocyte monocultures, measured by 
Gfap promoter-driven Lck-GCaMP3 fluorescence changes in astrocytes. A Representative images of 
transduced astrocytes, where estimated territories (marked in blue) were analysed for Ca
2+
 events in 
the soma (green), branchlets (red), and microdomains (yellow). The approximate cell territory was 
used to define sub-domains using GECIquant. Example dF/F traces represent Ca
2+
 fluctuations from 
three regions of interest (ROIs) for each sub-domain as detected and quantified using the semi -
automated software GECIquant. B Quantitation of event frequency, amplitude, and half-width for each 
sub-domain type for different culture types. C Quantitation of events as before, but comparing soma, 
branchlets, and microdomains within the same culture type. Note that the scale of y axes is different in 
frequency and event duration analyses for different culture types. MATLAB analysis was done by Ankit 
Awasthi (European Neuroscience Institute, Gött ingen). Four culture types were analysed, where n=3 
analysed videos per culture type with n=3 cells per culture type (i.e. 1 cell in each of 12 analysed 
videos); ROIs (somata): n=3 (co-culture, MD, NB+H), n=4 (IP); ROIs (branchlets): n=153 (co-culture), 
n=12 (MD), n=5 (IP), n=46 (NB+H); ROIs (microdomains): n=301 (co-culture), n=319 (MD), n=31 (IP), 
n=148 (NB+H). Error bars: SEM, *= p < 0.05, **= p < 0.01, ***= p < 0.001 by unpaired two-tailed 
Student’s t test. Scalebar = 20 µm. 
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for co-culture and NB+H astrocytes). Further differences included that in all three domains    
–soma, branchlets, microdomains– the Ca2+ event duration varied significantly across cultures 
(but was the same for MD and IP astrocytes).  
 Despite these dissimilarities, all infected astrocytes had in common that microdomains 
showed similar Ca2+ event frequency and somata showed similar Ca2+ event amplitude. Apart 
from MD astrocytes, all cultures also showed similar Ca2+ event amplitude in branchlets. 
Lastly, microdomains shared similar characteristics in all culture conditions, i.e. short, high-
amplitude Ca2+ events that differed significantly from those in somata and branchlets. 
 Because NB+H astrocytes were most similar to astrocytes grown in more “in vivo-like” 
conditions in co-cultures with neurones –by morphology, markers of cell maturity, and Ca2+ 
signalling– we concluded that NB+H astrocytes generated using our novel protocol were 
superior to other astrocyte monoculture methods. 
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4.2 Evidence for vesicles in astrocytes 
4.2.1 Astrocytes contain vesicular organelles 
 
Ultrastructural and structured illumination microscopic analysis has previously revealed that 
astrocytes contain (possibly exocytotic) vesicles of approximately 30 nm in diameter (Bezzi et 
al., 2004; Martineau et al., 2013) or up to 300 nm (Singh et al., 2014). Here, we compared co-
cultures with MD, IP, and NB+H astrocyte monocultures by electron microscopy to assess if 
these cultures contain vesicles (Fig. 14). Apart from MD astrocytes, all cultures featured 
clathrin-coated vesicles. We also found late endosomal multivesicular bodies in MD 
astrocytes (data not shown), while the IP astrocyte shown contained a lysosome (Fig. 1). 
However, electron microscopy of cell cultures is difficult because the extracellular space is 
greater than in vivo, making samples prone to damage during preparation, which can lead to 
artefacts and difficulties in identification of true vesicular structures and organelles. We 
therefore decided instead to focus our efforts on identification of vesicle-associated proteins 
and functional recycling of these proteins in astrocytes in response to stimulation, as shown in 
later figures. In summary, by electron microscopy, all culture types contained vesicular 
organelles, although such a general statement can be made for any cell. 






Fig. 14: Cultured astrocytes contain different vesicular organelles 
Electron microscopy of DIV14 co-cultures, and MD, IP, and NB+H astrocytes. All images show 
ribosomes (white arrowheads). Mitochondria (M) appear in the NB+H culture, and all astrocytes 
feature cytoskeletal filaments (black arrows). Apart from MD astrocytes, all cultures also feature 
clathrin-coated vesicles (black arrowheads). The IP culture contains a lysosome (L) and the NB+H 
culture contains multivesicular bodies (asterisks). Pictures were prepared by Dr. Wiebke Möbius and 
Torben Ruhwedel (MPI for Experimental Medicine, Göttingen). n=7 (co -culture), 6 (MD), 14 (IP), and 
12 (NB+H) images for each condition were collected, and showed similar characteristics . Scalebar = 
500 nm. 
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4.2.2 Astrocytes express vesicle-associated proteins 
 
To assess the presence of vesicle-associated proteins in astrocytes, we compared adult rat 
brain and co-culture lysate to MD, IP, and NB+H astrocyte lysate by Western blot analysis 
(Fig. 15). Some proteins that form the SNARE complex for vesicle fusion in neurones also 
appeared in MD, IP, and NB+H astrocyte samples: syntaxin1, a SNARE protein associated 
with the neuronal plasma membrane, and Vamp2, a synaptic vesicle-associated SNARE 
protein important for controlled vesicle exocytosis (Schoch et al., 2001). In contrast, Snap25 
and Rab3a were only expressed in samples that contained neurones.  
 In neurones, vesicular glutamate transporters (vGluTs) load synaptic vesicles with the 
neurotransmitter glutamate; here, vGluT isoforms 1 and 2 were absent from astrocyte 
monocultures, whereas vGluT3 was expressed in all samples. 
 





Several publications have reported that astrocytes express Vamp2 (Bezzi et al., 2004; 
Crippa et al., 2006). These findings were recently challenged by a report that astrocytes were 
devoid of Vamp2, but this was only found in MD cultures (Li et al., 2015). In brain slices, 
Vamp2 co- localises with Gfap by 3D reconstruction methods (Bergami et al., 2008). Since 
co-cultures and astrocyte monocultures all expressed Vamp2 in our Western blots and 




Fig. 15: Astrocytes express vesicle-associated proteins 
Western blot analysis of adult rat brain lysate compared with DIV14 co-culture, and MD, IP, and NB+H 
astrocyte monoculture lysates. Proteins that form the SNARE complex in neuronal vesicle fusion, 
syntaxin1 (Stx1) and Vamp2 both appear in all samples, whereas Snap25 is absent from astrocyte 
monocultures. Vamp4 and vesicular glutamate transporter (vGluT) 3 are expressed in all samples, 
while Rab3a and vGluT1 and 2 are not expressed in astrocyte monocultures.  Gapdh serves as a 
loading control (note that the same Gapdh blot appears in Fig. 10), where samples were processed 
together. Western blots were prepared by Dr. Saheeb Ahmed (European Neuroscience Institute, 
Göttingen). 
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4.2.3 Vamp2-harbouring vesicles: Localisation and recycling 
 
To analyse Vamp2 localisation in astrocytes, we stained co-cultures and astrocyte 
monocultures for Vamp2 by immunocytochemistry (Fig. 16). Vamp2 signal was apparent in 
all cultures, as expected given the detection of Vamp2 in Western blots (Fig. 15), and Vamp2 
staining appeared punctate. 
 




Fig. 16: Endogenous Vamp2 is distributed sparsely in astrocyte monocultures 
Immunocytochemistry of DIV14 co-cultures and DIV16 MD, IP, and NB+H astrocytes comparing 
Vamp2 distribution, where Gfap labels astrocytes in co-cultures, and Actin labels all cells in astrocyte 
monocultures. In co-cultures, Vamp2 is also expressed by other cells (presumably neurones) 
surrounding astrocytes. Images per experiment: n=5 for all conditions. Scalebar = 10 µm. 
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 In neurones, Vamp2 is involved in exocytotic vesicle release (Schoch et al., 2001). 
Since regulated vesicle-mediated exocytosis is under debate in astrocytes, and only little 
evidence for specific exocytotic marker proteins in astrocytes exists (Fiacco et al., 2009), we 
first tested if Vamp2 is found on vesicles that recycle via exo- and endocytosis in astrocytes. 
 In neurones and HeLa cells, Vamp2 co- localises with endocytotic / recycling vesicles 
(Bonanomi et al., 2007; Koo et al., 2011; Zylbersztejn et al., 2012). Consistent with this, 
Vamp2 regulates endosomal vesicle fusion in rat kidney cells (Jo et al., 1995). Our co-
immunostains of Vamp2 and the early endosomal protein EEA1 (a Vamp2-negative 
organelle) showed that co-cultures and astrocyte monocultures expressed both of these 
proteins (Fig. 17A). In co-cultures as well as IP and NB+H astrocytes, Vamp2 and EEA1 
rarely co- localised. However, MD astrocytes showed several puncta positive for both Vamp2 
and EEA1. The same was true in co-stains of Vamp2 and the late endosomal protein Rab7 
(Fig. 17B), which co- localised in several puncta in MD astrocytes, but only rarely in co-
cultures, IP, and NB+H astrocytes. This indicates that MD astrocytes differ from astrocytes 
cultured by other means in that Vamp2 was often found on (or very close to) endosomal 
vesicles in MD astrocytes. 
In addition, all astrocyte culture types had more EEA1- and Rab7-positive puncta than 
Vamp2-positive puncta. Thus, only a small population of total EEA1- and Rab7-harbouring 
endosomes co-localised with Vamp2. 
 
 





(see next page for Figure legend) 




Fig. 17: Vamp2 partly co-localises with endosomal proteins in MD astrocytes 
Immunocytochemistry of DIV14 co-cultures and DIV16 MD, IP, and NB+H astrocytes, where Vamp2, 
EEA1, and Rab7 antibodies label vesicle-associated proteins, early endosomes, and late endosomes, 
respectively, Gfap labels astrocytes in co-cultures, and Actin labels all cells in astrocyte monocultures. 
A Vamp2 co-localises with the early endosomal protein EEA1 and B the late endosomal protein Rab7 
(arrowheads) in several areas of MD astrocytes, but only rarely in co-culture, IP, or NB+H astrocytes. 
Images per experiment: n=6 (co-culture), n=10 (MD, IP), n=11 (NB+H). Scalebar = 10 µm, 5 µm for 
zoom-ins. 
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To investigate Vamp2 function in astrocytes, we next performed an internalisation 
assay on astrocytes, by which recycling Vamp2-harbouring vesicles can be identified. We 
transfected co-cultures, MD, IP, and NB+H astrocytes with GFP coupled to the lumenal 
domain of Vamp2. Astrocytes expressing GFP-Vamp2 were stimulated by placing them in  
50 µM glutamate solution for 10 minutes to initiate vesicle fusion (as described in Bittner et 
al. (2011)). Anti-GFP antibodies present in the stimulation solution label GFP-Vamp2-
harbouring vesicles that recycle – where the GFP on the lumenal domain of Vamp2 is 
exposed to the extracellular solution allowing GFP antibodies to bind before vesicles are 
endocytosed (as explained in Fig. 18A). 
In all astrocyte culture preparations, the somata contained several puncta with 
transfected GFP-Vamp2 that showed no anti-GFP antibody uptake (Fig. 18B) as expected, 
since vesicle recycling occurs at the cell membrane. In astrocytic processes, however, most 
GFP-Vamp2-positive puncta were also labelled by anti-GFP antibodies, indicating antibody 
uptake via vesicle recycling. Notably, MD astrocytes featured no fine processes, and antibody 
uptake was less profound in the outer edges of MD astrocytes compared with thin astrocytic 
processes in other culture preparations. 
We also performed a parallel experiment, in which we kept astrocytes in basal 2 mM 
KCl solution without stimulating them (Dallwig et al., 2000; Härtel et al., 2007). However, 
the staining pattern was similar to that following stimulation of astrocytes with 50 µM 
glutamate (data not shown), suggesting that astrocytes constitutively recycle Vamp2-
harbouring vesicles. We next tested if antibody uptake in astrocytes of co-cultures would be 
inhibited at 4 ºC, when vesicle recycling should be stalled. Compared with co-cultures at      
37 ºC, there was less co-localisation of total GFP-Vamp2 with anti-GFP antibodies at 4 ºC, 
but a considerable amount of GFP antibody signal was still detected on cells at 4 ºC (Fig. 
18C). We also tested if anti-GFP antibodies label GFP-Vamp2 protein that remained at the 
cell surface at 37 ºC by fixing –but  not permeabilising– cells after the internalisation assay, 
and then adding a second anti-GFP antibody to label only extracellular GFP-Vamp2 domains 
(explained in Fig. 18D). However, only little GFP-Vamp2 was exposed to the extracellular 
space (Fig. 18E), so that much of the anti-GFP antibody uptake resulted from vesicle 
recycling or endocytosis. 





(see next page for Figure legend) 





 We next tested if vesicle recycling was blocked by cleaving Vamp2 with tetanus 
toxin. We treated cultures with tetanus toxin light chain peptides (TeNT) to cleave Vamp2, 
which results in blockade of vesicle recycling via the SNARE proteins (Schiavo et al., 2000), 
but does not cleave the lumenal GFP domain coupled to Vamp2-harbouring vesicles 
(explained in Fig. 19A). We initially set up co-cultures, MD, IP, and NB+H astrocytes for this 
experiment, but IP astrocytes did not survive the transfection and TeNT treatment. 
    
Fig. 18: Astrocytes recycle Vamp2-harbouring vesicles in cell cultures 
Internalisation assays show anti-GFP antibody uptake by astrocytes transfected with GFP-Vamp2 two 
days before the assay. A Schematic explaining the internalisation assay: GFP-Vamp2-harbouring 
vesicles in live astrocytes that fuse with the cell membrane upon stimulation with 50 µM glutamate 
solution expose their lumenally tagged GFP to the extracellular solution which contains anti -GFP 
antibodies that target GFP-Vamp2. These antibodies are then internalised in vesicles via endocytosis. 
B Immunocytochemistry of DIV14 co-cultures and DIV16 MD, IP, and NB+H astrocytes (identified by 
Aldh1L1) shows that transfected GFP -Vamp2 and anti-GFP antibodies that have been taken up by 
recycling GFP-Vamp2 vesicles are often distinct in the soma but co-localise in astrocytic processes.   
C Immunocytochemistry of the same experiment performed in DIV14 co -cultures at 4 ºC shows 
slightly less uptake than at 37 ºC (A); only few punctate regions stained positive for GFP-Vamp2 but 
negative for anti-GFP antibody uptake (white arrowheads). D Schematic explaining how in E, DIV14 
co-cultures were fixed without permeabilising the membrane, so that a second antibody (2nd a.b. ) 
labelled only GFP-Vamp2 molecules at the membrane. In this assay, very little GFP-Vamp2 was found 
at the membrane (blue dashed square), and only few puncta stained positive for GFP-Vamp2 but 
negative for anti-GFP antibody uptake (white arrowheads). Images per experiment: n=6 for all 
conditions. Scalebar = 10 µm, 5 µm for zoom-ins. 
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 When TeNT was applied to cultures,  astrocytes showed a drastic decrease in anti-GFP 
antibody uptake (Fig. 19B): Co-culture, MD, and NB+H astrocytes still expressed puncta 
positive for transfected GFP-Vamp2, but showed only little or (as in the case of MD 
astrocytes) no antibody uptake at all. Therefore, TeNT blocked the function of transfected 
Vamp2 in astrocytes. 
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Fig. 19: TeNT blocks GFP-Vamp2 vesicle recycling in astrocytes in vivo 
Internalisation assay showing almost no antibody uptake by astrocytes transfected with GFP-Vamp2 
and tetanus toxin light chain peptides (TeNT). A Schematic explaining how Vamp2 in GFP-Vamp2-
harbouring vesicles is cleaved by TeNT in live astrocytes. Vesicles can then no longer fuse with the 
cell membrane. B Immunocytochemistry of DIV14 co-cultures and DIV16 MD, and NB+H astrocytes 
(as identified by Aldh1L1) shows that transfected GFP-Vamp2 and GFP antibody uptake only rarely 
co-localise (arrowheads) in astrocyte processes. Images per experiment: n=8 (co-culture), 19 (MD), 
17 (NB+H). Scalebar = 10 µm, 5 µm for zoom-ins. 
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4.2.4 Syt-harbouring vesicles: Localisation and recycling 
 
The structure of a synapse shows how closely astrocytes are associated with neurones: Fine 
astrocytic processes engulf neuronal synapses, where astrocytes take up excess 
neurotransmitter, but also release glial factors (Hamilton and Attwell, 2010; Parpura and 
Zorec, 2010). We found that our “in vivo-like” cultured astrocytes not only developed fine 
processes, but also exhibited distinct Ca2+ events in those processes (Fig. 13). 
On a molecular level, we found that astrocytes expressed the vesicle-associated 
proteins syntaxin1 and Vamp2, which were previously suggested to form SNARE complexes 
for regulated vesicle release in astrocytes (Maienschein et al., 1999). In agreement with these 
observations, we found that Vamp2-harbouring vesicles were recycled in fine astrocyte 
processes, and this recycling was blocked when TeNT cleaved Vamp2. In neurones, the 
SNARE complex initiates vesicle fusion in response to a local [Ca2+] rise (Jahn and 
Fasshauer, 2012), which is detected by Syt1 and 2. Since astrocytes express mRNA of 
different Syt isoforms in vivo (Mittelsteadt et al., 2009), we next investigated whether 
cultured astrocytes express Syt protein. 
First, we tested if astrocytes express Syt isoforms for which mRNA was previously 
found in astrocytes by Mittelsteadt et al. (2009): The authors found that astrocytes express 
Syt4, 7, and 11; we further assessed Syt17 as a previously untested candidate. Indeed, we 
found Syt4, 7, 11, and also Syt17 protein in astrocyte monocultures, but not Syt1, 3, or 5 by 
Western blot analysis (Fig. 20). Syt7 antibodies detected multiple bands, consistent with 
multiple Syt7 splice isoforms as reported by Fukuda et al. (2002). 
 
 





 Next, we focused on Syt subcellular distribution in astrocytes, for which we compared 
two anti-Syt7 antibodies by immunocytochemistry and Western blot analysis of wild-type 
(Wt) and Syt7-/- samples (Fig. 21). Only one of the antibodies (raised in rabbit) targeted 
proteins in a punctate pattern both in neurones and astrocytes from co-cultures (Fig. 21A). 
When applying the same antibody to Wt or Syt7-/- co-cultures, a punctate staining pattern 
appeared only in Wt cultures (Fig. 21B). Similarly, the same antibody detected Syt7 protein in 
Syt7+/+ and Syt7+/-, but not Syt7-/- mouse brain lysate (Fig. 21C). One band of low signal 
intensity appeared in all brain lysate samples, but this was below 45 kDa, at which Syt7 bands 
have not been reported. In summary, the Syt7 antibody raised in rabbit recognized Syt7 
protein specifically both in immunostainings and Western blots. 
 
 
Fig. 20: Astrocytes express several synaptotagmin isoforms 
Western blot analysis of adult rat brain lysate compared with DIV14 co-culture, MD, IP, or NB+H 
astrocyte monoculture lysates. Several synaptotagmin (Syt) isoforms appear in astrocyte 
monocultures, i.e. Syt4, 7, 11, and 17, but not Syt1, 3, or 5. As previously reported by Fukuda et al. 
(2002), Syt7 has multiple splice isoforms, here at 46, 70, and ≈80 kDa (arrowheads). Gapdh is used 
as a loading control. 





 To test if Syts can be localised in astrocytes in vivo, we first tested a negative control 
using Syt1 (which is not expressed by astrocytes). However, in brain slices from perfused Wt 
mice (Fig. 22), Syt1 puncta seemingly co- localised with astrocytic processes, illustrating that 
this approach created false positive signals. Due to these methodological limitations, we did 
not pursue immunohistological stainings for other Syt isoforms and used our newly developed 




Fig. 21: Testing Syt7 antibodies on Wt and Syt7-/- samples 
A Immunocytochemistry of DIV14 rat wild-type (Wt) co-cultures stained for Syt7 using mouse 
monoclonal (m) and rabbit polyclonal (rb) antibodies, and Gfap. In zoomed-in images, punctate Syt7 
(rb) staining co-localises with Gfap staining (arrowheads) but also appears in neighbouring, unlabelled 
neuronal processes; no structures are stained by the Syt7 (m) antibody. B Immunocytochemistry of 
DIV14 mouse Wt versus Syt7
-/-
 co-cultures stained for Actin, Syt7 (rb), and the neuronal marker Map2. 
The Syt7 (rb) antibody labels punctate structures in Wt (arrowheads) but not Syt7
-/-
 cells. C Western 




 but not Syt7
-/-
, 
where tubulin serves as a loading control. Images per experiment: n=5 (A), 13 (B, Wt), 12 (B, Syt7
-/-
). 
Scalebar = 10 µm, 5 µm for zoom-ins. 






 According to the Western blot in Fig. 20, astrocytes express Syt4, 7, 11, and 17. We 
therefore analysed the distribution of these four Syt isoforms via immunocytochemistry in co-
culture and NB+H astrocytes, which developed fine processes in culture and showed similar 
Ca2+ signalling profiles (Fig. 13). For all four Syt isoforms, we found punctate staining 
patterns (Fig. 23). In co-cultures, astrocytes and neurones both expressed these Syt isoforms, 
where Syt17 staining was more prominent in astrocytes than in neurones. In addition, a subset 
of astrocytes (about one third of all astrocytes) expressed high levels of Syt4, 7, and 11 in 
both culture types, whereas Syt17 was ubiquitously expressed amongst all astrocytes 
(personal observation). These data confirm the Western blot analysis in Fig. 20, i.e. astrocytes 
express at least four different Syt isoforms in cell cultures. 
 
 
Fig. 22: Syt1 expression near astrocytes in vivo 
Immunohistochemistry of coronal cortical sections from perfused adult Wt mice showing Syt1 and 
Gfap distribution. In the zoomed-in images, Syt1 puncta appear to co-localise with the astrocyte-
specific Gfap (arrowheads). Control immunohistochemistry of goat anti-mouse AlexaFluor488-
conjugated (m488) or goat anti-guinea pig AlexaFluor647-conjugated (gp647) secondary antibodies. 
Images per experiment: n=5 for all conditions. Scalebar = 20 µm, 10 µm for zoom-ins. 





 Since the staining patterns of all four Syt isoforms were punctate just like the staining 
pattern of Vamp2, and both protein classes are involved in vesicle fusion (Lang and Jahn, 
2008; Südhof, 2002), we next tested if Syts and Vamp2 co- localise in astrocytes. In co-
stainings of Syt4, 7, 11, or 17 with Vamp2, we found that these Syts and Vamp2 do not 
localise to the same vesicles (puncta) in astrocytes (Fig. 24A). In co-cultures, Syt1 co-
localised with Vamp2 in neurones, but not with Aldh1L1 that marked astrocytic processes. To 
test if even a small subpopulation of Vamp2-harbouring vesicles contained any Syt isoforms 
in addition, we analysed the images using MetaMorph co-localisation analysis software (Fig. 
24B). This co- localisation analysis confirmed our observations, i.e. Vamp2 did not co- localise 
with Syt4, 7, 11, or 17 in astrocytes (but did colocalise with Syt1 in neurones). This implies 
that Vamp2 and Syts are found on distinct vesicles / organelles in astrocytes. 
 
 
Fig. 23: Syt staining appears punctate in co-culture and NB+H astrocytes 
Immunocytochemistry of Syt isoforms with Gfap (to label astrocytes in DIV14 co-cultures) or Actin (to 
label all cells in DIV16 NB+H astrocyte monocultures). Punctate staining for Syt4 (A), Syt7 (B), Syt11 
(C), and Syt17 (D) appears in astrocytes of all cultures. Images per experiment: n=3 (co-cultures in A, 
C, D), 6 (co-culture in B), 5 (NB+H in A, D), 3 (NB+H in B, C). Scalebar = 10 µm. 




Fig. 24: Syts do not co-localise with Vamp2 in NB+H astrocytes 
A Immunocytochemistry to detect if Syt isoforms co-localise with Vamp2 in DIV16 NB+H astrocytes, 
where staining for Syt1 and Vamp2 in DIV14 co-cultures serves as a positive control; Aldh1L1 labels 
astrocytes. In NB+H astrocytes, there is almost no co-localisation of Syt4, 7, 11, or 17 with Vamp2, 
whereas most Syt1 puncta in co-cultures co-localise with Vamp2. B Bar graphs represent percentages 
of Syt puncta, Vamp2 puncta, and puncta positive for both as found by co-localisation analysis using 
MetaMorph software. Images per experiment: n=7 (Syt4), 8 (Syt7), 6 (Syt11), 7 (Syt17), 4 (Syt1). 
Scalebar = 10 µm. 
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Unlike Vamp2, several Syt isoforms are considered Ca2+ sensors, including Syt7 and 
17 (Bhalla et al., 2005, 2008). If any Syts are involved in Ca2+-dependent exocytosis in 
astrocytes, they may be located on small exocytotic vesicles as in neurones, or on lysosomes: 
Previous work reported lysosomes as the main vesicular organelle involved in astrocytic 
exocytosis (Li et al., 2008). Moreover, studies in rat kidney cells and mouse embryonic 
fibroblasts revealed Syt7 as a crucial regulator of Ca2+-dependent lysosomal exocytosis 
(Jaiswal et al., 2004; Rao et al., 2004). To assess if Syt7 also mediates lysosomal exocytosis 
in astrocytes, we tested whether Syt7 co-localises with lysosome-associated membrane 
glycoprotein 1 (Lamp1) (Fig. 25). However, Syt7 and Lamp1 did not co- localise. Thus, we 
considered the possibility that Syt7 is associated with small exocytotic vesicles in astrocytes. 
 




Fig. 25: Syt7 and Lamp1 do not co-localise in astrocytes 
Immunocytochemistry of DIV14 co-cultures and DIV16 MD, IP, and NB+H astrocytes to detect if Syt7 
co-localises with the lysosomal protein Lamp1 in astrocytes; Aldh1L1 labels astrocytes in co-cultures, 
Actin labels all cells in astrocyte monocultures. Syt7 and Lamp1 do not co-localise (arrowheads). 
Images per experiment: n=6 for all conditions. Scalebar = 10 µm, 5 µm for zoom-ins. 
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4.2.4.1 Syt7 vesicle recycling 
 
In endocrine cells, Syt7 was reported to act as a high-affinity Ca2+ sensor, and was found on 
large dense core vesicles (and lysosomes) (Wang et al., 2005). In neuroendocrine cells, Syt7 
was found to regulate the dynamics of vesicle fusion pores that open and expand during 
exocytosis (Segovia et al., 2010), thus affecting the stability of fusion pores and if vesicles 
undergo transient or full fusion. To test recycling of Syt7-harbouring vesicles, we performed 
antibody internalisation assays as before (Fig. 18) by stimulating astrocytes transfected with 
GFP-Syt7 (Fig. 26) in the presence of extracellular solution containing GFP antibodies. 
 In response to 50 µM glutamate solution, GFP-Syt7-transfected astrocytes showed 
anti-GFP antibody uptake, with the same uptake pattern under unstimulated conditions (data 
not shown). Compared to previous internalisation assays, GFP-Syt7-transfected astrocytes 
displayed slightly less anti-GFP antibody uptake (i.e. vesicle recycling) than GFP-Vamp2-
transfected astrocytes (Fig. 18). 






Fig. 26: Astrocytes recycle some Syt7-harbouring vesicles 
Internalisation assay showing antibody uptake by astrocytes transfected with GFP-Syt7 when 
stimulated with 50 µM glutamate solution (see schematic in Fig. 11A). Immunocytochemistry of DIV14 
co-cultures and DIV16 MD, IP, and NB+H astrocytes (as identified by Aldh1L1) shows that some 
puncta positive for GFP-Syt7 co-localise with antibody uptake staining (arrowheads). MD astrocytes 
show anti-GFP antibody uptake in the cell periphery, whereas co-culture, IP, and NB+H astrocytes 
possess thin processes in which anti-GFP antibody was taken up. Images per experiment: n=8 (co-
culture), 6 (MD), 3 (IP), 7 (NB+H). Scalebar = 10 µm, 5 µm for zoom-ins. 
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To exclude that anti-GFP antibody is taken up by endosomes without being bound to 
its GFP antigen, we also transfected astrocytes with GFP-Syt17 (Fig. 27) – since Syt17 lacks 
a transmembrane domain, this GFP-Syt17 fusion protein is not exposed to the lumen of 
vesicles (although it is membrane-associated (Craxton, 2010)). Thus, anti-GFP antibodies 
would have no access to GFP antigens on GFP-Syt17 protein. Indeed, we found no co-
localisation of GFP-Syt17 with anti-GFP antibodies following the internalisation assay in 
stimulated (Fig. 27) or unstimulated conditions (data not shown).  
 
 




Fig. 27: Astrocytes do not take up anti-GFP antibodies via GFP-Syt17-harbouring 
vesicles 
Internalisation assay to test for GFP antibody uptake by astrocytes transfected with GFP-Syt17 when 
stimulated with 50 µM glutamate solution (see schematic in Fig. 11A). Immunocytochemistry of DIV14 
co-cultures and DIV16 MD, IP, and NB+H astrocytes (as identified by Aldh1L1) shows no GFP 
antibody uptake, as Syt17 lacks a transmembrane domain and GFP-Syt17 can therefore not be 
incorporated as an integral vesicle membrane protein (with GFP in the lumen) like Syt7 (Fig. 26). 
Images per experiment: n=4 (co-culture), 6 (MD), 3 (IP), 6 (NB+H). Scalebar = 10 µm. 
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4.3 Syt7 in development and synaptogenesis 
4.3.1 Syt7 is developmentally regulated in astrocytes 
 
In Syt7 immunostainings, we noticed that 3-week-old astrocytes contained fewer Syt7 puncta 
than 2-week-old astrocytes (Fig. 23). To follow up this observation, we compared Syt7 
staining in DIV16 and DIV21 IP and NB+H astrocyte monocultures, since these were 
morphologically closer to astrocytes in vivo than MD astrocytes, but lacked neurones that also 
express Syt7. As observed in preliminary tests, astrocytes expressed more Syt7 on DIV14 
than on DIV21 in immunostains of both IP and NB+H astrocytes (Fig. 28A). Quantification 
revealed that Syt7 puncta were significantly more numerous in DIV14 astrocytes than DIV21 
(Fig. 28B). To test whether this reflected a decrease in Syt7 protein levels during 
development, we analysed NB+H astrocytes grown in culture for 9, 14, and 21 days by 
Western blot (Fig. 28C). Here, DIV14 astrocytes expressed the highest levels of the Syt7 
isoform of 46 kDa (matching the predicted molecular weight of Syt7 (Uniprot Consortium, 
2012)), whereas the Syt7 levels of isoform 46 were decreased in DIV9 and DIV21 astrocytes. 
 















Fig. 28: Syt7 is developmentally regulated in astrocytes 
Comparing Syt7 expression in IP and NB+H astrocytes on DIV16 versus DIV21. A Immuno-
cytochemistry showing Syt7 and Actin staining, where Syt7 is punctate and expressed at higher levels 
on DIV16 than on DIV21. B Bar graph showing absolute numbers of Syt7 puncta in DIV16 versus 
DIV21 IP and NB+H astrocytes. C Western blot analysis of Syt7 expressed by NB+H astrocytes on 
DIV9, DIV14, and DIV21. As previously reported, multiple Syt7 splice isoforms appear, of which the 46 
kDa isoform (which is missing in Syt7
-/-
 mice) is expressed at higher levels on DIV14. Images per 
experiment: n=4 (DIV16), 3 (DIV21). Error bars: SEM, *= p < 0.05, ***= p < 0.001 by unpaired two-
tailed Student’s t test. Scalebar = 10 µm. 
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4.3.2 Synapse number decreases when astrocytes lack Syt7 
 
Both immunocytochemistry and Western blot analysis showed that Syt7 expression was 
upregulated in astrocytes after two weeks in culture. In cultured neurones, synapses form and 
stabilise between DIV10 and DIV14 (Goslin et al., 1990), suggesting that Syt7 is expressed at 
the right time to be involved in synaptogenesis. To investigate a role of Syt7 in synapse 
formation, we plated Wt neurones on either Wt astrocytes or Syt7-/- astrocytes (Fig. 29A). In 
contrast to Wt co-cultures, neurones grown on Syt7-/- astrocytes showed fewer Syp puncta, 
which mark synapses. Quantification confirmed this, where synapse number significantly 
decreased by half depending on whether astrocytes expressed Syt7 (Fig. 29B). 
 To analyse if not only synapse number, but also synapse function was impaired in co-
cultures with Syt7-/- astrocytes, we stimulated co-cultures containing Wt astrocytes or 
containing Syt7-/- astrocytes with 50 mM KCl solution that contained anti-Syt1 lumenal 
domain antibodies. As in the previous internalisation assays, anti-Syt1 antibodies only bind to 
the lumenal domain of Syt1 upon Syt1 vesicle fusion with the membrane, thus reporting Syt1 
(synaptic) vesicle recycling. In both co-culture types, most Syp-positive puncta co-localised 
with anti-Syt1 antibodies (Fig. 29C). The number of Syp- and Syt1-positive puncta following 
the internalisation assay was significantly decreased in Wt neurones cultured on Syt7-/- 
astrocytes, compared to Wt neurones on Wt astrocytes. Thus, neurones co-cultured with   
Syt7-/- astrocytes featured fewer but functional synapses (as assessed by the internalisation 
assay) compared with neurones co-cultured with Wt astrocytes. 
 




Fig. 29: Neurones have fewer synapses when grown on Syt7-/- astrocytes 
A Immunocytochemistry showing synapse distribution by synaptophysin (Syp) staining in DIV14 Wt 
neurones co-cultured with Wt or Syt7
-/-
 astrocytes. B Bar graph comparing absolute synapse numbers 
between the two conditions shown in A. C Internalisation assay showing Syt1 antibody uptake by 
DIV14 neurones grown on Wt or Syt7
-/-
 astrocytes when stimulated with 50 mM KCl solution. Syt1 
antibody uptake co-localises with Syp staining (arrowheads). Images per experiment: n=10 for all 
conditions. Error bars: SEM, ***= p < 0.001 by unpaired two-tailed Student’s t test. Scalebar = 10 µm, 
5 µm for zoom-ins. 
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Here, astrocytic Syt7 affected neuronal synapse number, which points to the 
possibility of Syt7-mediated release of glial factors involved in synaptogenesis. Astrocytes 
express and release several synaptogenic factors that are important for synapse formation and 
refinement in early postnatal development, e.g. Hevin, thrombospondins (TSPs), or glypicans 
(Allen et al., 2012; Christopherson et al., 2005; Kucukdereli et al., 2011). However, how 
these synaptogenic factors are released from astrocytes is currently unknown. 
Compared to the Syt7 expression pattern we found, TSP1 mRNA expression and 
Hevin protein expression in the mouse brain peak at similar timepoints (Iruela-Arispe et al., 
1993; Kucukdereli et al., 2011). Therefore, we investigated if NB+H astrocytes also 
developmentally regulate synaptogenic factors that are released by astrocytes in vivo. 
In Western blots of DIV9, 14, and 21 NB+H astrocytes, Hevin was expressed at lower 
levels on DIV9 but was upregulated on DIV14 and 21 (Fig. 30A). In contrast, glypican6 
protein levels remained unaltered, and TSP1 was downregulated between DIV14 and DIV21 
(although the Western blot was much less clear than for Hevin). Since, like Syt7, Hevin was 
upregulated between DIV9 and DIV14, we next investigated if Hevin co-localises with Syt7-
harbouring vesicles in co-culture or NB+H astrocytes. We found that astrocytes expressed 
both Hevin and Syt7 by immunocytochemistry, and several (but not all) Hevin puncta co-
localised with Syt7 vesicles (Fig. 30B). 
In summary, astrocytes developmentally regulated both Hevin and Syt7 expression, 
and Hevin co- localised with a subset of several Syt7 vesicles, suggesting that Hevin may be a 









Fig. 30: Hevin is developmentally regulated in astrocytes, and partly co-localises with 
Syt7 
A Western blot analysis of different synaptogenic factors expressed by NB+H astrocytes on DIV9, 14, 
and 21. Hevin is predicted to run at 75 kDa, but migrates at ≈130 kDa according to the manufacturer 
and Kuckdereli et al. (2011); thrombospondin1 (TSP1) runs between 150 and 180 kDa; glypican6 
(GPC6) runs at 85-95 kDa. Hevin expression is upregulated on DIV14 and 21, whereas TSP1 and 
GPC6 expression remains unaltered. Gapdh serves as a loading control (note that the same Gapdh 
blot appears in Fig. 28, where samples were processed together). Western blots were prepared by 
Dr. Saheeb Ahmed (European Neuroscience Institute, Göttingen). B Immunocytochemistry of DIV14 
co-cultures and DIV16 NB+H astrocytes shows that several Syt7 puncta co-localise with Hevin 
(arrowheads). Images per experiment: n=6 for all conditions in B. Scalebar = 10 µm and 5 µm for 
zoom-ins. 




Synaptic signalling and plasticity are not solely a neuronal matter: Astrocytes greatly affect 
synapse function, e.g. by taking up excess neurotransmitters from, and releasing glial factors 
into, the synaptic cleft (Barker and Ullian, 2010; Perea et al., 2009), or by influencing synapse 
development (Clarke and Barres, 2013; Eroglu and Barres, 2010). To influence synaptic 
signalling, plasticity, and development, astrocytic factors must be released somehow, but the 
release mechanism is unclear. So far, several models for the underlying molecular mechanism 
were suggested, including vesicle-associated proteins which promote astrocytic exocytosis 
from small synaptic- like microvesicles, dense core vesicles, or lysosomes (Santello et al., 
2012). Although astrocytes express several vesicle-associated proteins that could steer 
vesicular release, controlled vesicular exocytosis in astrocytes is under debate (Fiacco et al., 
2009; Hamilton and Attwell, 2010; Martineau, 2013; Sloan and Barres, 2014b; Vardjan and 
Zorec, 2015). 
 Therefore, the goal of this project was to analyse the potential role of vesicle-
associated proteins in astrocytic vesicle fusion, and the effects of astrocytic vesicle fusion on 
synaptic function. 
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5.1 Astrocyte morphology and protein expression depend on 
the medium 
To study the recycling and molecular composition of astrocytic vesicles, we first needed a cell 
culture system that allowed us to focus on astrocytes only (without surrounding neurones that 
also express some of the vesicle-associated proteins found in astrocytes). However, protocols 
for growing astrocyte monocultures are suboptimal in that they are lengthy (3 months for 
iPSC-derived astrocytes (Krencik and Zhang, 2011)), generate polygonal, reactive astrocytes 
(MD method (McCarthy and de Vellis, 1980)), or produce very low yields of stellate 
astrocytes using relatively expensive reagents (IP method (Foo et al., 2011)). Thus, we 
developed a high-yield, fast, economical, and simple protocol for growing stellate “NB+H” 
astrocyte monocultures in chemically defined, serum-free medium. 
 NB+H astrocytes were similar to astrocytes co-cultured with neurones and to “in vivo-
like” IP astrocytes (Foo et al., 2011) by morphology and protein expression, e.g. they featured 
thin processes and astrocyte-specific proteins. Also, NB+H astrocytes contained lower levels 
of Vimentin than MD astrocytes, which marks immature and reactive astrocytes (Dahl et al., 
1981; Pixley and de Vellis, 1984; Schnitzer et al., 1981), and higher levels of S100β, which 
labels mature astrocytes that lost their neural stem cell potential (Raponi et al., 2007), than 
MD and IP astrocytes. This indicates that NB+H astrocytes are more “in vivo-like” and more 
mature than MD astrocytes. In addition, NB+H cultures were free of other glia and neurones. 
Our Western blot analysis showed that IP astrocytes expressed the lowest Vimentin 
levels (i.e. fewer immature or reactive astrocytes), compared with other culture methods we 
tested, but this may be due to either the IP method itself, or to the tissue age, since IP 
astrocytes are usually prepared from P7 tissue. To test this, we prepared viable and stellate 
NB+H astrocytes from P7 tissue, which is the source of IP astrocytes, and compared the 
morphology in P7-derived NB+H and IP astrocytes. In both cases, astrocytes appeared 
stellate, although NB+H astrocytes showed lower Gfap expression levels by immunostaining. 
In future experiments, comparing Vimentin and S100β expression levels might reveal if 
NB+H and IP astrocytes maturity still differs when dissected from similarly aged tissue. The 
maximal tissue age reported to successfully generate IP astrocytes is P14, whereas NB+ H 
astrocytes can likely be derived from older (or even adult) tissue, too, since the core technique 
(the MD method) successfully generates adult-derived astrocyte cultures (Schwartz and 
Wilson, 1992; Souza et al., 2013).  
Discussion – 5.1 Astrocyte morphology and protein expression depend on the medium 
 
 115 
For astrocytes prepared by any protocol, we found that the medium composition 
defined the morphology: Growing astrocytes in Neurobasal medium with the growth factor 
HBEGF always generated stellate cells. When cultured in NB+H, IP astrocytes 
downregulated Gfap expression to near-undetectable levels, a sign of non-reactive cortical 
astrocytes similar to in vivo conditions. Thus, immunopanning may yield more “in vivo-like” 
astrocytes when using NB+H medium rather than NB+H with DMEM as described by Foo et 
al. (2011). 
 HBEGF belongs to the epidermal growth factor family (Prigent and Lemoine, 1992; 
Raab and Klagsbrun, 1997) and induces downstream transcriptional changes (Korotkevych et 
al., 2015). By binding to the ErbB3 receptor, HBEGF may indirectly induce proliferation, cell 
migration, differentiation, or apoptosis (Citri and Yarden, 2006; Galati, 2012). IP astrocytes 
are thought to require HBEGF to prevent apoptosis (Foo et al., 2011), yet we found that 
astrocytes proliferate less without HBEGF, but still survive. In line with our findings, a recent 
study comparing 2D to 3D mouse cultures also reports astrocyte survival but less proliferation 
in the absence of HBEGF (Puschmann et al., 2014). However, Puschmann et al. (2014) 
claimed that astrocytes partially de-differentiate in the presence of HBEGF. We did not 
observe any de-differentiation in the presence of HBEGF, but we only used half the 
concentration of HBEGF that Puschmann et al. used, and allowed astrocytes to mature for at 
least 16 days (versus 8-10 days in Puschmann et al.). In line with Puschmann et al., our 
findings suggest that HBEGF promotes astrocyte proliferation and stellate morphology 
without any de-differentiation effects at the concentrations and culture times we used to 
generate NB+H astrocytes. 
Recently, astrocytes derived from human fetal tissue were successfully grown in 
serum-containing medium in 3D matrices (Placone et al., 2015); yet how such human cultures 
would look with HBEGF as a substitute for serum is not yet known and signifies another 
potential role for HBEGF in cell culture systems. 
 In summary, astrocytes change morphology and protein expression depending on the 
medium they are grown in. In particular, we found that HBEGF induces stellate astrocyte 
morphology, and this effect was strongest when adding HBEGF to Neurobasal medium.  
 
Discussion – 5.2 Ca
2+





 signalling differs amongst astrocyte culture 
methods 
Astrocytes communicate largely through Ca2+ signalling, where Ca2+ sources include internal 
Ca2+ stores (e.g. the endoplasmic reticulum or mitochondria) and extracellular Ca2+ 
(transported into the cell by transporters or voltage- and ligand-operated channels) (Deitmer et 
al., 2009). Until recently, astrocytic Ca2+ signalling was studied by patch-clamp recordings 
(e.g. as in Zur Nieden and Deitmer (2006)) or by loading organic Ca2+ indicator dyes into the 
cell (e.g. Fluo-4, Oregon Green BAPTA1, or rhod-2 (Nimmerjahn et al., 2004; Takano et al., 
2006)). Genetically encoded Ca2+ indicators (GECIs) are now widely used, where the Gfap 
promoter-driven membrane-tethered Lck-GCaMP3 was shown to be superior to organic Ca2+ 
indicator dyes (Shigetomi et al., 2013a) for measuring Ca2+ responses in astrocytes: Lck-
GCaMP3 allows visualisation of Ca2+ fluctuations in even the fine astrocytic processes, 
whereas the commonly used Fluo-4 detects mainly somatic [Ca2+] changes (Reeves et al., 
2011). Therefore, we analysed astrocytic Ca2+ signalling using Lck-GCaMP3, where its 
expression was driven with an astrocyte-specific Gfap promoter.  
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5.2.1 Astrocytic Ca2+ signalling occurs in somata, branchlets, and 
microdomains 
 
As in astrocytes in brain slices (Shigetomi et al., 2013a) and in vivo (Srinivasan et al., 2015), 
our data from cultured NB+H astrocytes show that Lck-GCaMP reports Ca2+ signalling across 
the entire territory of astrocytes, segregated into three domains: somata, branchlets, and 
microdomains. In somata, the Ca2+ event amplitude was similar in all cultures tested (co-
culture, MD, IP, and NB+H). In branchlets, amplitude was also similar between culture 
preparations (except for a slightly higher amplitude in MD astrocytes). This suggests that the 
amplitude of somatic and branchlet Ca2+ fluctuations is conserved in astrocytes of different 
culture types. 
In contrast, Ca2+ event duration in somata, branchlets, and microdomains was more 
variable across all cultures. However, NB+H astrocyte event duration in all three 
compartments was comparable to co-cultured (more in vivo-like) astrocytes. In contrast, MD 
and IP astrocytes event durations did not resemble those of co-cultures. Microdomains always 
produced the highest-amplitude, shortest Ca2+ events compared with somata and branchlets 
(in all culture types). Microdomains of co-culture astrocytes exhibited significantly lower 
Ca2+ event amplitude than monoculture astrocytes. Thus, in the absence of neurones, 
astrocytes showed more pronounced microdomain responses. However, microdomains in all 
cultures showed similar Ca2+ event frequency.  
 Our results are comparable to Ca2+ fluctuations in brain slices (Shigetomi et al., 
2013a) and in vivo (Srinivasan et al., 2015): Ca2+ event frequency and amplitude are similar 
as summarised in Table 2 (although standard error values are high in some cases). In contrast, 
Ca2+ event duration was longer in cultured astrocytes than in astrocytes in brain slices and in 
vivo. This could be a result of the stringent criteria we applied to define Ca2+ events, in which 
we chose thresholds such that we could be sure of “real” events, which may exclude smaller 
events that are closer to the noise. Although our culture experiments cannot be directly 
compared to brain slices or in vivo data, given possible differences in methods and analysis, 
the similarity in Ca2+ event frequency and amplitude suggests that co-culture and NB+H (but 
not MD and IP) astrocytes are a good model for studying Ca2+ fluctuations in cultures. 
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Table 2: Comparing our results on astrocytic Ca2+ signalling to slices and in vivo data 
Tables summarising the frequency, amplitude, and duration of Ca
2+
 signalling events from our culture 
analysis (see Fig. 13BC) to slices (Shigetomi et al., 2013a) and in vivo (Srinivasan et al., 2015) data. 
Although the differences in experimental setups do not allow for a direct comparison, this summary 
illustrates that Ca
2+
 signalling in cultures (in vitro) is similar to Ca
2+
 signalling in slices (in situ) or in 
vivo. Apart from half-width values for data from slices (derived from Cyto-GCaMP3 experiments), all 
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5.2.2 Co-culture and NB+H astrocytes exhibit similar Ca2+ signalling 
profiles 
 
Ca2+ event duration in co-culture and NB+H astrocytes was more similar to Ca2+ event 
duration in brain slices and in vivo than that of MD and IP astrocytes (Table 2). Moreover, no 
or very few events were detected in somata and branchlets of MD and IP astrocytes, i.e. Ca2+ 
fluctuation frequency in brain slices / in vivo was generally more similar to that of co-culture 
and NB+H astrocytes. 
 While microdomain Ca2+ event frequency was comparable across all cultures (around 
0.4 events / min), somata and branchlets showed two ranges of Ca2+ event frequencies: (1) 0.8 
to 1.2 events / min occurred in co-culture and NB+H astrocytes, and (2) < 0.2 events / min 
occurred in MD and IP astrocytes. 
Moreover, Ca2+ events had shorter durations in somata and branchlets, and longer 
durations in microdomains of co-culture and NB+H astrocytes; the opposite was true for MD 
and IP astrocytes. Thus, differences in Ca2+ event duration also divided cell cultures into two 
groups (co-culture / NB+H astrocytes versus MD / IP astrocytes). 
What mechanism underlies differences in Ca2+ fluctuations in different domains? It 
was hypothesised that astrocytic Ca2+ activity depends on inositol triphosphate type 2 receptor 
(IP3R2)-dependent release from internal Ca2+ stores in the endoplasmic reticulum, since 
Ip3r2-/- mouse astrocytes no longer show Ca2+ fluctuations as measured by organic Ca2+ 
indicator dyes (Agulhon et al., 2010; Petravicz et al., 2008). However, when membrane-
tethered GECIs were used to visualise Ca2+ activity in awake adult Ip3r2-/- mice, Ca2+ 
fluctuations persisted (although at decreased frequency, amplitude, and duration), and 
depleting intracellular Ca2+ stores with cyclopiazonic acid in wild-type mice yielded similar 
Ca2+ fluctuations as in Ip3r2-/- mice (Srinivasan et al., 2015). These Ca2+ fluctuations made up 
half or more of the total branchlet and microdomain Ca2+ activity and were IP3R2-
independent. In addition to intracellular Ca2+ stores, branchlet and microdomain Ca2+ 
fluctuations employ extracellular Ca2+: removing extracellular Ca2+ abolishes branchlet and 
microdomain Ca2+ activity, and subsequently restoring extracellular Ca2+ causes branchlet and 
microdomain Ca2+ fluctuations to reappear. Such transmembrane Ca2+ fluxes may be due to 
Ca2+ channels (e.g. TRPA1 channels) and transporters (e.g. the Na+/Ca2+ exchanger) that 
traffic extracellular Ca2+ into the cytosol (Kirischuk et al., 1997; Minelli et al., 2007; 
Shigetomi et al., 2013b). 
Discussion – 5.2.2 Co-culture and NB+H astrocytes exhibit similar Ca
2+
 signalling profiles 
 
 120 
Following these observations, it would be interesting to test how cyclopiazonic acid 
and Ca2+-free extracellular solution affect astrocytic Ca2+ events in cell cultures. If in cultures, 
astrocyte subcompartments (partly) rely on both IP3R2-dependent release from intracellular 
Ca2+ stores and extracellular Ca2+ via Ca2+ channels for fast and local Ca2+ events as in brain 
slices, Ca2+ fluctuations should decrease in response to cyclopiazonic acid, Ca2+-free 
extracellular solution, or both. Somata, branchlets, and microdomains may also access 
different Ca2+ sources in cultured astrocytes. As detected by organic Ca2+ indicator dyes, 
removing extracellular Ca2+ has a direct, negative effect on astrocytic Ca2+ event frequency of 
expanded events (i.e. larger amplitude in several neighbouring domains) but not single 
domains (Di Castro et al., 2011). The same study found a branchlet event frequency of 1.8 
events / min, i.e. much lower than in Lck-GCaMP-based in vivo experiments, stressing that 
GECIs are more sophisticated than organic dyes for measuring astrocytic Ca2+ signalling. 
We successfully expressed Lck-GCaMP3 in cultured astrocytes, and found that the 
Ca2+ activity in NB+H astrocytes mimics brain slice and in vivo Ca2+ fluctuations. This 
illustrates that monitoring Ca2+ signalling in a culture system closer to an in vivo-like state is 
possible. This allows the study of astrocytes isolated from neuronal influence, but also 
permits imaging all processes of an astrocyte within a small z plane due to the monoculture’s 
2D nature. Our study is the first to analyse Ca2+ signalling in IP astrocytes transduced with 
Lck-GCaMP3, and the first to compare astrocytic Ca2+ signalling of somata, branchlets, and 
microdomains across different cell cultures using the semi-automated software GECIquant. 
Therefore, further studies are required to validate our findings. 
If astrocyte Ca2+ signalling in the soma differs from branchlets and microdomains, 
which processes do these three domains compute? As for somatic Ca2+ fluctuations, both our 
results and previous studies show that these Ca2+ transients are much slower and often less 
frequent than branchlet and microdomain Ca2+ events. Slow somatic Ca2+ signalling is 
associated with prolonged blood-oxygen- level-dependent signals (Schulz et al., 2012). 
However, the slow nature of somatic Ca2+ fluctuations also led some groups to question how 
relevant astrocytic Ca2+ signalling is for neurovascular coupling (Nizar et al., 2013). Yet, 
further Ca2+ studies using Fluo-4 and GECIs in astrocytes revealed that vascular responses are 
functionally and temporally linked to astrocytic Ca2+ signalling, but that a majority of these 
events appear in branchlets (Kim et al., 2015b; Otsu et al., 2015). Thus, Ca2+ fluctuations in 
the somata and branchlets of astrocytes may relate to more large-scale events like vascular 
responses. 
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Apart from a putative role in neurovascular coupling, Ca2+ fluctuations in astrocytic 
branchlets may also reflect neighbouring axonal firing, since adding tetrodotoxin to 
hippocampal slices significantly decreases astrocytic Ca2+ signalling (Serrano et al., 2006). 
Further, Ca2+ signalling in hypothalamic astrocytes evokes increased synaptic currents, but 
only in neuronal processes directly bordering the astrocyte with increased Ca2+ activity 
(Gordon et al., 2009). In response to synaptic activity, Ca2+ fluctuations in astrocytic 
branchlets increase, resulting in gliotransmitter release, which in turn affects basal synaptic 
transmission (Panatier et al., 2011). Taken together, these findings suggest that Ca2+ 
signalling in astrocytic branchlets may mediate communication between single astrocytes and 
neurones, e.g. via gliotransmitter release. 
While Ca2+ signalling in astrocytic branchlets diminishes when neurones are treated 
with tetrodotoxin, microdomain Ca2+ fluctuations persist (Di Castro et al., 2011). Thus, 
microdomain Ca2+ concentration likely is not influenced by neuronal firing, but may change if 
these fine astrocytic processes detect spontaneous synaptic activity. 
As individual synapses can function independently in neurones, microdomains and 
branchlets may present an analogous structure in astrocytes that can quickly respond to local 
challenges, e.g. synaptic signalling and plasticity at tripartite synapses. 
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5.3 Astrocytes express some vesicle-associated proteins, 
including synaptotagmins 
Astrocytes feature several vesicular organelles, including endocytic clathrin-coated vesicles 
and multivesicular bodies, but also putative exocytotic vesicles ranging from 30 to 300 nm in 
diameter (Bezzi et al., 2004; Martineau et al., 2013; Singh et al., 2014). We also found 
vesicular organelles in astrocytes by electron microscopy, and further detected several 
vesicle-associated proteins in astrocytes in Western blots. We validated previous reports of 
syntaxin1 and Vamp2 in astrocytes (Jeftinija et al., 1997; Parpura et al., 1995), and further 
found endogenous Vamp4 in astrocytes, which had only been reported in the Golgi body of 
oligodendrocytic glia before (Feldmann et al., 2009). MD astrocytes likely recycle the 
neuromodulator tPA via Vamp4, since transfected EGFP-Vamp4 co- localises with 
exogenously applied tPA in MD astrocytes (Cassé et al., 2012). Therefore, it would be 
interesting to test if exogenous tPA is also recycled via Vamp4-harbouring vesicles in more in 
vivo-like NB+H astrocytes. 
In neurones, syntaxin1 and Vamp2 form the SNARE complex (together with Snap25) 
for exocytotic synaptic vesicle fusion (Hanson et al., 1997; Jahn and Scheller, 2006). 
Similarly, astrocytic syntaxin1 and Vamp2 may control exocytotic astrocytic vesicle fusion 
with Snap23, the astrocytic homologue of Snap25 (Hepp et al., 1999; Montana et al., 2004; 
Wilhelm et al., 2004). While neuronal exocytotic synaptic vesicles also pass through docking 
and priming stages before being released (Südhof, 2013), there is yet no evidence for the 
molecules that mediate these processes in astrocytes, i.e. Munc13 isoforms, RIM active zone 
proteins, or vesicle-associated Rab3a (Fiacco et al., 2009). We found no Rab3a in astrocytes, 
but other proteins remain to be tested. While the lack of similar vesicle docking / priming 
molecules in astrocytes as compared with neurones supports the view that there is no 
controlled exocytotic vesicle release in astrocytes, astrocytes may simply employ other 
molecules for vesicle docking and priming. For instance, Snap23, which astrocytes express, 
mediates secretory granule docking in endocrine cells (Chieregatti et al., 2004), similar to 
Snap25, which regulates synaptic vesicle docking in neurones (Mohrmann et al., 2013; de Wit 
et al., 2009). Alternatively, astrocyte vesicles may dock and fuse at the right place and time by 
other, as of yet unknown mechanisms.  
Nonetheless, the pool of astrocytic vesicle-associated proteins is extensive, and the 
interactions between individual proteins are still being investigated, e.g. in addition to Vamp2 
and Vamp4, astrocytes also express Vamp3 (Li et al., 2015; Parpura et al., 1995; Schubert et 
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al., 2011) and syntaxin isoforms 2, 3, and 4 (Paco et al., 2009; Tao-Cheng et al., 2015). 
Astrocytes may also express more vesicle-associated proteins than tested here, which further 
Western blot analysis will show. 
In addition to SNARE proteins, we also found that astrocytes express vGluT isoform 
3, which transports glutamate into synaptic vesicles in neurones (Fremeau et al., 2002; Nelson 
et al., 2014). Since astrocytes were also suggested to release gliotransmitters like glutamate 
via exocytotic vesicles (Martineau, 2013; Santello et al., 2012), glutamate would first have to 
be loaded into these vesicles, e.g. via vGluTs. Several groups found one or more of the three 
vGluT isoforms in astrocytes (Anlauf and Derouiche, 2005; Bezzi et al., 2004; Montana et al., 
2004), although other reports claim that astrocytes express no vGluTs at all (Li et al., 2013). 
In line with this, (2011) observed no glutamate release when stimulating MD and IP 
astrocytes with ATP. However, astrocytes released glutamate in several other studies both in 
cell culture (Araque et al., 1999; Hassinger et al., 1995; Parpura et al., 1994) and in brain 
slices (Angulo et al., 2004; Bezzi et al., 2004; Fellin et al., 2004; Jourdain et al., 2007), and 
immunogold cytochemistry revealed glutamate on small synaptic-like microvesicles in 
astrocytes in the adult hippocampus (Bergersen et al., 2012). Further, immunogold- labelling 
in astrocytes revealed vGluT3 as the most abundant isoform in vivo (Ormel et al., 2012). 
Unlike vGluT1 or 2, vGluT3 overexpression increased glutamate release from cultured 
astrocytes (Ni and Parpura, 2009). These studies illustrate that vGluT3 may be involved in 
glutamate release from astrocytes by exocytotic vesicles. 
In general, regulated vesicular exocytosis in astrocytes is still under debate (Hamilton 
and Attwell, 2010; Parpura and Zorec, 2010; Sahlender et al., 2014; Sloan and Barres, 
2014b). This debate partly comes from inconsistent findings in MD astrocytes, e.g. some 
studies find Vamp2 in astrocytes (Araque et al., 2000; Bezzi et al., 1998; Coco et al., 2003; 
Crippa et al., 2006), which was challenged by a report (Li et al., 2015) using similar culture 
conditions that include serum-containing media that are prone to varying quality. Other 
groups identified Vamp2 co- localisation with more established astrocyte markers like Gfap in 
brain slices using 3D reconstruction methods (Bergami et al., 2008), which provide better 
resolution than optical planes. Using the NB+H monoculture protocol for stellate astrocytes, 
with a defined medium that does not contain serum, we found that astrocytes express Vamp2 
via both Western blot analysis and immunocytochemistry. In addition, astrocytic vesicles can 
be isolated using anti-Vamp2 antibodies (Martineau et al., 2013), and Vamp2-harbouring 
vesicles are highly mobile (Singh et al., 2014) but mediate slow vesicular release (Zorec et al., 
2015) 
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 If astrocytes also control regulated vesicle fusion, this would implicate another class 
of molecules, which in neurones initiates vesicle fusion by sensing local intracellular [Ca2+] 
elevations: synaptotagmins (Syts). Since we showed that Ca2+ signalling in cultured astrocytes 
is spatially divided into different cellular subcompartments (soma, branchlets, microdomains) 
as in vivo, with domain-specific kinetics, local Ca2+ fluctuations may well be involved in 
regulated vesicle exocytosis in astrocytes. Indeed, astrocytes express both mRNA 
(Mittelsteadt et al., 2009) and protein of several Syt isoforms (Cahoy et al., 2008; Zhang et 
al., 2004a). In line with this study, we found that cultured astrocytes express Syt isoforms 4, 
7, 11, as reported in Mittelsteadt et al., and 17 (but not 1, 3, and 5). Overall, our data show 
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5.4 Vamp2 and Syt7 mark distinct vesicle populations in 
astrocytes 
Our immunostainings of Vamp2 and Syt7 vesicles showed punctate protein distribution in 
astrocytes, with an enrichment of signal in astrocytic processes (in those cultures with stellate 
morphology). Similarly, Vamp2- and Syt7-harbouring vesicles recycled in fine astrocytic 
processes when stimulated with glutamate. The majority of GFP-Vamp2-harbouring vesicles 
recycled in basal, non-stimulated conditions (2 mM KCl), where only a fraction of GFP-
Vamp2 remained within the cell membrane and was not internalised by recycling vesicles. 
These findings from cultured astrocytes hint at constitutive recycling of vesicles that include 
Syt7 and Vamp2. 
 At 4 ºC, vesicle trafficking is inhibited (Kuismanen and Saraste, 1989). Although a 
slight decrease in vesicle recycling was observed in internalisation assays of GFP-Vamp2-
transfected astrocytes, most anti-GFP antibodies were still taken up by cells at 4 ºC in our 
experiments. Since we did not observe a dramatic decrease in vesicle recycling at 4 ºC versus 
37 ºC, we concluded that inhibiting membrane trafficking at 4 ºC might have failed. However, 
other studies also show no change or only a slight reduction in vesicular antibody uptake at    
4 ºC (Helmy et al., 2006; Iglesias-Bartolomé et al., 2006).  
In internalisation assays, both Vamp2- and Syt7-harbouring vesicles recycled. Since 
Vamp2 and Syt1 are both essential parts of the SNARE complex in neurones, Vamp2 and 
astrocytic Syt isoforms may also act together in astrocytes. In neurones, Vamp2 catalyses 
membrane fusion and stabilises the SNARE complex (Schoch et al., 2001), and the Ca2+ 
sensor Syt1 is required for fast, synchronous vesicle release in neurones (Geppert et al., 
1994). Vamp2-/-, Syt1-/-, and Syt2-/- mutants show a severe phenotype and die soon after birth 
(Pang et al., 2006), whereas mutants lacking other Syt isoforms in the brain have milder 
phenotypes, e.g. deficits in learning and memory as the Syt4-/- mutant (Ferguson et al., 2000). 
Due to the differential roles of Syts in neurones, we hypothesised that astrocytes may 
also employ Vamp2 alongside several Syts for different aspects of vesicle fusion (e.g. 
transient versus full fusion, or fusion of different vesicle or organelle types). Despite their 
similar staining patterns and recycling in internalisation assays, Syt7 and Vamp2 did not co-
localise. Therefore, we concluded that Syt7 and Vamp2 are associated with different vesicle 
subtypes in cultured astrocytes. 
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Apart from Vamp2 and Syt7, we also performed internalisation assays using Syt17 as 
a negative control, since this Syt isoform lacks a transmembrane domain (Fukuda and 
Mikoshiba, 2001b) and the GFP domain of GFP-Syt17 is therefore not exposed to the 
vesicular lumen. Syt17 is associated with vesicular membranes, however, and appears in mass 
spectrometric analyses of purified synaptic vesicles alongside other (transmembrane domain-
containing) Syt isoforms (Takamori et al., 2006). Therefore, Syt17-harbouring vesicles may 
recycle in astrocytes, but this would not be detected by internalisation assays. However, total 
internal reflection fluorescence microscopy of MD astrocytes transfected with pHluorin-
coupled Syt17 revealed spontaneous pH-dependent GFP fluorescence changes indicating 
vesicle fusion with the membrane (Anne Wolfes, unpublished data). Further, Syt7 and 17 
were reported to selectively recycle in axons (and not dendrites) of neurones, assayed by 
pHluorin-Syt reporter constructs (Dean et al., 2012). In our experiments, Syt17 worked as a 
negative control (suggesting that Syt17 does indeed lack a transmembrane domain), and we 
saw no internalisation of GFP antibodies by GFP-Syt17 expressing cells in stimulated or 
unstimulated conditions. In a study referring to Syt17 as B/K protein, Syt17 localised to the 
trans-Golgi network (where proteins are assembled for lysosomal, secretory vesicle, or 
transport to the cell membrane) of PC12 cells (Fukuda and Mikoshiba, 2001a). Thus, it may 
be interesting to test which subcellular compartments Syt17 localises to in astrocytes. 
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5.4.1 Vamp2 is rarely localised to endosomes in astrocytes 
 
Previously, Vamp2 was found on endocytotic / recycling vesicles in neurones and HeLa cells 
(Bonanomi et al., 2007; Koo et al., 2011; Zylbersztejn et al., 2012). In rat kidney, Vamp2 
mediates endosomal fusion of vesicles (Jo et al., 1995). We therefore also tested if Vamp2 is 
localised to astrocytic endosomes. Vamp2 and early (EEA1-positive) as well as late (Rab7-
positive) endosomal markers only partly co- localised, and only in MD astrocyte cultures. 
While this implies that MD astrocytes may express Vamp2 on endosomal vesicles, it also 
stresses the difference between the polygonal MD astrocytes and stellate astrocytes of other 
culture types; Vamp2 is rarely localised on endosomes in MD astrocytes, and likely exempt 
from endosomes in more in vivo-like astrocyte cultures. 
 If Vamp2 is not localised to endosomes, lysosomes and small exocytotic vesicles are 
other candidates for Vamp2 integration. In astrocytes in mouse hippocampal cultures, both 
lysosomes and small exocytotic vesicles fuse with the membrane in a Ca2+-dependent manner 
(Liu et al., 2011). In the same study, Vamp2 and Vamp3 co- localised to small vesicles (but 
not lysosomes), and glutamate release (but not lysosomal membrane fusion) was Vamp2-
dependent (as TeNT blocked it). Thus, these small vesicles were required for release of 
glutamate, as suggested in previous studies (Crippa et al., 2006; Martineau et al., 2008), so 
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5.4.2 Syt7 is not localised to lysosomes 
 
In contrast to Vamp2, where most reports focus on neuronal exocytotic vesicles, Syt7 is 
associated with lysosomes in rat kidney and mouse embryonic fibroblasts (Jaiswal et al., 
2004; Martinez et al., 2000; Rao et al., 2004), and in hippocampal neurones (Monterrat et al., 
2007). Functionally, Syt7 was further associated with Ca2+-dependent lysosomal exocytosis, 
where Syt7 influences the formation of lysosomal fusion pores (Jaiswal et al., 2004). In PC12 
cells, Syt7 localises to lysosomes and large dense-core vesicles, but not to synaptic- like 
microvesicles (Fukuda et al., 2002, 2004). 
Because Syt7 mediates lysosomal exocytosis in fibroblasts and PC12 cells and 
lysosomes are the main vesicular organelle implicated in astrocytic exocytosis (Li et al., 
2008), we hypothesised that Syt7 may be present on lysosomes to regulate their fusion in 
astrocytes. However, our immunocytochemistry analysis revealed that in cultured astrocytes, 
Syt7 does not co-localise with lysosomes. Since GFP-Syt7 internalisation assays showed that 
Syt7-harbouring vesicles recycle, however, we conclude that Syt7 localises to other vesicular 
organelles that undergo active recycling. 
Compared with Syt1, the Ca2+ sensitivity of Syt7 is ≈400-fold higher (Bhalla et al., 
2005). Syt7 was suggested as a Ca2+ sensor in asynchronous vesicle release, since the 
disassembly kinetics of Syt7 (assayed in vitro using liposomes) are the slowest amongst all 
Syts (Hui et al., 2005). These properties make Syt7 a good candidate for mediating Ca2+-
dependent vesicular fusion in astrocytes, where Ca2+ concentrations may be lower than in 
neuronal active zones following an action potential, and thus require a higher affinity Ca2+ 
sensor. Ca2+-dependent vesicle fusion of both lysosomes and small vesicles occurs in cultured 
mouse hippocampal astrocytes, where small vesicles release glutamate (Liu et al., 2011) and 
may release other cargo. Glutamate release from astrocytes significantly decreases (but does 
not vanish) when Vamp2 (and Vamp3) are blocked with clostridial toxins (Liu et al. 2011). 
Since in our cultures, Syts did not co-localise with Vamp2 in astrocytes, only a fraction of 
glutamate release may be mediated by Syt7-harbouring vesicles, if any. However, Syt7-
harbouring vesicles may contain other cargo than glutamate, as is discussed in chapter 5.6. 
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5.5 Astrocytic Syt7 is involved in synaptogenesis 
The goal of this project was to identify molecules involved in astrocyte vesicle fusion at 
synaptic interfaces. Here, we focused on Syt7, which we found expressed in astrocytes and 
which has a very high Ca2+ sensitivity (Bhalla et al., 2005) (see previous chapter). According 
to our findings, Syt7 may be involved in synaptogenesis. During prenatal development and 
several days before synapse formation, most neurones of the central nervous system innervate 
their future targets (Pfrieger and Barres, 1996). However, synapses only form after 
astrogliogenesis begins (Ullian et al., 2001). In general, astrocytes shape synaptogenesis by 
releasing different synaptogenic factors both in cultures and in vivo (Eroglu, 2009; McKellar 
and Shatz, 2009). 
 We found that when astrocytes (but not neurones) lack Syt7, synapse number 
decreases significantly. When DIV14 neurones cultured with Syt7-/- astrocytes were 
stimulated, synaptic vesicles recycled normally, suggesting that synaptic function is 
unaffected, and only synapse number is reduced. Our results suggest that astrocytic Syt7 is 
involved in synaptogenesis, but do not show whether this is due to changes in synapse 
formation, stabilisation, or elimination. In cultures, synapse formation and stabilisation occur 
between DIV10 and DIV14 in hippocampal neurones (Goslin et al., 1990), and synapse 
elimination occurs between DIV6 and 11 in corticospinal neurones (Ohno and Sakurai, 2005). 
Considering that our results showed a ≈50% decrease in synapse number, but not a complete 
loss of synapses in DIV14 cultures, we propose that astrocytic Syt7 plays a role in synaptic 
refinement rather than formation. In line with this, removing astrocytic trophic support from 
co-cultures (in which synapses had begun to form) on DIV7 causes most synapses to 
disappear by DIV14 (Ullian et al., 2001). If Syt7 plays a role in synapse formation, we might 
therefore expect a more dramatic effect on synapse loss than a reduction by 50%.  Thus, Syt7 
in astrocytes may more likely support synaptic stabilisation or refinement. 
Our data do not directly address whether fewer synapses form, or whether synapses 
form normally but are not stabilised. Interestingly, Syt7-/- mice showed no neuronal phenotype 
(Chakrabarti et al., 2003) and no change in neurotransmitter release and short-term plasticity 
(Maximov et al., 2008). Given unaffected neuronal networks in Syt7-/- mice, there are two 
possible explanations of reduced synapse numbers on cultured Syt7-/- astrocytes: (1) fewer 
synapses form in the absence of Syt7, so that fewer synapses compete for stabilisation, i.e. 
there is less synapse elimination, but the number of synaptic connections is the same as in 
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wild-type; (2) synapses form but are not stabilised, possibly creating a lower threshold for 
synapse elimination, and a higher turnover of synapses during development, but still leading 
to synaptic refinement. In both scenarios, functional neuronal network are established despite 
reduced synapse formation, or reduced synapse formation due to the absence of Syt7 in 
astrocytes – evolutionarily, this would imply that synapse elimination only arose because 
having many synapses compete for stabilisation is a good thing (possibly to guarantee enough 
functional synaptic connections); yet it is strange that Syt7-/- mice are unaffected by less 
stringent synapse competition and elimination. Considering that in humans, atypical wiring 
may have mild symptoms (e.g. as in autism spectrum disorders), it is possible that more 
delicate, milder aspects of the Syt7-/- phenotype have been overlooked. 
Since no neuronal phenotype was reported for Syt7-/- mice, removing astrocytic Syt7 
may have a more pronounced effect in cultures than in vivo. Therefore, it would be interesting 
to compare cortical synapse numbers at different developmental stages of Syt7-/- mice (or 
mice lacking Syt7 only in astrocytes, e.g. under an astrocyte-specific promoter like Gfap, used 
for knockdown). To find out whether synapse formation, stabilisation, or elimination involves 
astrocytic Syt7 and how this is reflected in vivo, more detailed analyses are required, e.g. 
studying synaptic strength in Syt7-/- early postnatal versus adolescent and adult mutant mice to 
assess if synapses are stabilised and functionally normal compared with Wt animals. In light 
of normal neuronal function in Syt7-/- mice, Syt7 may only be involved during a small time 
window of synaptogenesis, so that any impairments due to Syt7 absence in astrocytes may 
only have minor consequences. 
 In summary, astrocytic Syt7 is involved in the synaptogenesis of cultured neurones, 
but to what extent this is true in vivo remains to be tested. 
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5.6 Astrocytes developmentally regulate Syt7 and Hevin 
Astrocytes developmentally regulate Syt7, where the 46 kDa isoform is upregulated between 
DIV14 and 16. This roughly matches Drosophila Syt7 expression, which is only upregulated 
as the nervous system begins to form (Adolfsen et al., 2004). Since synapse numbers are 
decreased in DIV14 neurones co-cultured with Syt7-/- astrocytes, we hypothesise that 
astrocytes mediate synapse number by releasing glial factors from Syt7-harbouring vesicles. 
 Synaptogenesis is affected by several astrocyte-secreted proteins, e.g. Hevin, SPARC, 
thrombospondins (TSPs), and glypicans (Allen et al., 2012; Eroglu, 2009; Jones and Bouvier, 
2014). Hevin-/- mice have fewer excitatory synapses, and Sparc-/- mice have more 
(Kucukdereli et al., 2011). Synapse number is unaltered in Tsp1-/- or Tsp2-/- mice, but 
decreases by 40% in Tsp1-/-/Tsp2-/- double knockout mice at P8, and by 25% at P21 
(Christopherson et al., 2005). Gpc4-/- mouse synapses are defective due to impaired glutamate 
receptor clustering (Allen et al., 2012). Amongst these astrocyte-secreted proteins, Hevin and 
SPARC are complementary positive and negative regulators of synapse formation, 
respectively (Kucukdereli et al., 2011), and astrocyte leaflets (which contact synapses) 
contain Hevin (Lively and Brown, 2008a; Lively et al., 2007). 
In our study, we found that cultured astrocytes upregulate Hevin (but not glypican6) 
expression between DIV9 and DIV14, and might slightly downregulate TSP1 expression on 
DIV21 (repetition is required to quantify changes in protein level). Similarly, astrocytes 
developmentally upregulate Hevin (at a time point comparable to our findings) and TSP1 in 
vivo (Iruela-Arispe et al., 1993; Kucukdereli et al., 2011), and release these glial factors to 
promote synaptogenesis (Christopherson et al., 2005; Hughes et al., 2010). We further found 
that Syt7-harbouring vesicles partly co- localise with Hevin. Since Hevin is released by 
astrocytes, and Syt7 is a Ca2+ sensor on vesicular organelles (e.g. synaptic vesicles in 
neurones (Liu et al., 2014) or lysosomes in fibroblasts (Martinez et al., 2000)), Hevin may be 
the cargo of vesicles whose molecular fusion mechanism involves Syt7. 
Based on our findings that synapse number decreases only by half in neurones grown 
on Syt7-/- astrocytes, we argued that astrocytic Syt7 affects synaptic refinement rather than 
synapse formation. Interestingly, astrocytes were reported to regulate synaptic refinement 
through Hevin (Risher et al., 2014), which supports our proposition that astrocytes regulate 
the refinement but not formation of synapses through Syt7. Specifically, thalamocortical 
synaptic connections are reduced in the Hevin-/- mouse cortex, whereas dendritic spines with 
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multiple excitatory synaptic connections increase. Injecting Hevin directly into Hevin-/- mouse 
cortices at P13 rescued this effect and promoted significantly more thalamocortical synapses 
after three days. This shows that astrocyte-derived Hevin is required for normal synaptic 
connectivity of long-distance projections of the thalamocortical tract. The results of this 
Hevin-/- mouse model analysis correlate with our observations that Hevin and Syt7 partially 




However, since we did not find complete co- localisation of Syt7 and Hevin, Syt7-
harbouring vesicles may contain other cargo (e.g. TSP1). To test if Syt7 and Hevin are 
functionally linked, recombinant Hevin could be used to potentially rescue synapse number in 
neurones cultured with Syt7-/- astrocytes. Since Hevin and SPARC both regulate synapse 
formation in a complementary fashion (either by enhancing or reducing synapse number), it is 
also possible that Syt7-harbouring vesicles traffic SPARC. However, synapse numbers 
 
Fig. 31: Model of Hevin released from astrocytes during synaptogenesis 
Schematic model of our findings. Astrocytes (blue) support and regulate synaptogenesis of 
nearby developing neurones (orange). In astrocytic processes, Vamp2 is localised to some 
vesicles (purple), while Syt7 is localised to other vesicles (green). Syt7-harbouring vesicles 
may traffic Hevin to the cell surface to release Hevin either locally to nearby developing 
synaptic connections (1) or globally, to release Hevin throughout the extracellular matrix (2). 
Astrocyte-derived Hevin release promotes synapse number, size, and synaptic vesicle 
number (Kucukdereli et al., 2011). This model can be applied to cell interactions in vivo and 
in co-cultures of astrocytes and neurones. 
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remain the same when culturing Wt neurones with Sparc-/- or with Wt astrocytes (Jones et al., 
2011), unlike our results of culturing Wt neurones with Syt7-/- versus Wt astrocytes. 
 Little is known about how astrocytes release synaptogenic factors at the right place 
and time in the developing nervous system (Allen, 2013; Clarke and Barres, 2013). To test if 
astrocytes not only express Syt7 in culture but also in vivo, FACS-based astrocyte isolation 
from Tg{Gfap::Gfp} or Tg{Aldh1L1::Gfp} mice would be useful for analysing how Syt7 (and 
synaptogenic factors) are regulated at different developmental stages. Understanding the 
molecular mechanisms by which glial cells shape neuronal networks would not only advance 
general knowledge on nervous system development, but may also aid in treatment of 
neurological diseases. Synapse refinement, which may be promoted by astrocytic Syt7, is a 
crucial step in nervous system development, without which neuronal networks become 
dysfunctional (Doll and Broadie, 2014; West and Greenberg, 2011). Not only neurones, but 
astrocytes too play an important role in neurodevelopmental diseases (Yang et al., 2013). 
Common symptoms in autism, schizophrenia, fragile X syndrome, and Down’s syndrome 
include cognitive impairment, epileptic seizures, and often abnormal synapse formation or 
function – all of which are associated with astrocytic function (Molofsky et al., 2012). On a 
molecular level, Hevin (which partly co- localised with Syt7) protein levels decrease following 
induced epileptic seizures in rodents, after which Hevin was associated with excitatory, but 
not inhibitory synaptic markers (Lively and Brown, 2008b). These findings suggest that 
Hevin is involved in synaptic modifications that underlie epileptogenesis. Another example 
comes from a mouse model of the fragile X syndrome, which showed reduced pre- and 
postsynaptic protein clusters at synapses and abnormal dendrite morphology, which was 
rescued by co-culturing mutant neurones with Wt astrocytes (Jacobs and Doering, 2010). In 
the reverse approach, culturing Wt neurones with astrocytes from Down’s syndrome patients 
reduced dendritic spine number and neuronal activity, and caused abnormal dendritic spine 
morphology (Garcia et al., 2010). This effect was rescued by adding TSP1, illustrating that 
astrocyte-secreted factors can restore neuronal connections in neurodevelopmental disease. 
Given the importance of astrocyte-secreted factors for developing synaptic 
connections, astrocytes represent an important target for therapeutic disease management. 
Thus, understanding how astrocytes release glial factors is essential not only for 
understanding the relationship between glia and neurones, but also for developing therapeutic 
agents to treat neurodevelopmental diseases. 
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5.7 Conclusion and future directives 
In support of regulated vesicular exocytosis, this study confirmed that cultured astrocytes 
express several vesicle-associated proteins (that were previously linked to gliotransmitter 
release), and showed that Vamp2- and Syt7-harbouring vesicles recycle in a similar fashion, 
although Vamp2 and Syt7 do not localise to the same vesicles. Interestingly, Syt7 and the 
synaptogenic factor Hevin are developmentally regulated by astrocytes, and partly co- localise 
in cultured astrocytes. Moreover, synapse number decreases if astrocytes (but not neurones) 
lack Syt7. To understand how astrocytes release synaptogenic factors, future experiments 
could address if other Syts and synaptogenic factors are developmentally regulated, and 
analyse Syt-regulated vesicle fusion mechanisms in vivo, e.g. by re-visiting Syt7-/- mouse 
behaviour in the light of astrocytic functional changes. 
To analyse vesicular release of glial compounds in astrocytes, we developed a fast, 
simple, and economical protocol for growing a high yield of stellate astrocytes. These cultures 
exhibited Ca2+ event frequency, amplitude, and duration similar to astrocytes co-cultured with 
neurones, but different from MD and IP astrocytes. These Ca2+ fluctuations and their 
subcellular localisations were comparable to those of astrocytes in brain slices and in vivo, 
suggesting that cultured astrocytes may employ similar Ca2+ signalling profiles. With this new 
protocol for astrocyte monocultures, follow-up experiments could investigate if astrocytic 
Ca2+ signalling and nearby Syt-mediated vesicle trafficking are linked, e.g. by monitoring 
Ca2+ signalling (using GCaMPs) together with astrocyte vesicle recycling (by transfecting 
cells with Syt7 coupled to a red pHluorin reporter). Alternatively, since improved red 
genetically encoded Ca2+ indicators like RCaMP2 are now available (Inoue et al., 2015), 
astrocytic Syt kinetics could be deciphered by simultaneous imaging of Ca2+ (through 
RCaMP2) and Syts coupled to green pH-sensitive fluorescent indicators of vesicle endo- / 
exocytosis called pHluorins (Miesenböck et al., 1998). In the absence of astrocytic (but not 
neuronal) Syt7, synapse numbers decrease, i.e. this astrocytic Syt isoform affects synaptic 
interfaces. Whether or not this happens at tripartite synapses, where astrocytic leaflets enwrap 
neuronal connections, or whether Syt7-harbouring vesicles mediate the global release of 
synaptogenic factors, remains to be tested. 
Astrocyte-derived synaptogenic factors are implicated in several common 
neurodevelopmental diseases like epilepsy or Down’s syndrome. Therefore, studying 
astrocytic vesicular release mechanisms may help clarify how astrocytes affect 
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